<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A0F5FE7C-8820-488E-9121-EEA8CF4C6CF3"><gtr:id>A0F5FE7C-8820-488E-9121-EEA8CF4C6CF3</gtr:id><gtr:name>NIHR Oxford Biomedical Research Centre</gtr:name><gtr:address><gtr:line1>Botnar Research Centre</gtr:line1><gtr:line2>Nuffield Orthopaedic centre</gtr:line2><gtr:line3>Windmill Rd</gtr:line3><gtr:postCode>OX3 7LD</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D6237E81-EC70-49B1-881F-9E0645D5D590"><gtr:id>D6237E81-EC70-49B1-881F-9E0645D5D590</gtr:id><gtr:name>University of Oviedo</gtr:name><gtr:address><gtr:line1>University of Oviedo</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/FAE32A25-51D3-49EF-998F-281B3A47C212"><gtr:id>FAE32A25-51D3-49EF-998F-281B3A47C212</gtr:id><gtr:name>Helmholtz Association of German Research Centres</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/42B56A32-9194-468C-A790-BE55133838A6"><gtr:id>42B56A32-9194-468C-A790-BE55133838A6</gtr:id><gtr:name>University of Hamburg</gtr:name><gtr:address><gtr:line1>ZMK</gtr:line1><gtr:line2>Blunderstrasse</gtr:line2><gtr:line4>Hamburg</gtr:line4><gtr:line5>20146</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3B1E5961-8677-4A32-B15C-12FB968FA163"><gtr:id>3B1E5961-8677-4A32-B15C-12FB968FA163</gtr:id><gtr:name>University of Pennsylvania</gtr:name><gtr:address><gtr:line1>3451 Walnut Street,</gtr:line1><gtr:line2>Suite P-221</gtr:line2><gtr:line3>Franklin Building</gtr:line3><gtr:line4>Philadelphia</gtr:line4><gtr:postCode>PA 19104</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/6EA29FCF-7F5D-4187-B33F-25000D54809E"><gtr:id>6EA29FCF-7F5D-4187-B33F-25000D54809E</gtr:id><gtr:name>Department of Health Social Services and Public Safety (DHSSPS)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/007E0817-B05C-490A-B38A-2EDA79558DDD"><gtr:id>007E0817-B05C-490A-B38A-2EDA79558DDD</gtr:id><gtr:name>Boston University</gtr:name><gtr:address><gtr:line1>One Sherborn Street</gtr:line1><gtr:line2>Boston</gtr:line2><gtr:line3>Massachusetts</gtr:line3><gtr:line4>MA 02215</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/4E67597F-C9AB-4ED2-BB87-FB1D1FC6FB6D"><gtr:id>4E67597F-C9AB-4ED2-BB87-FB1D1FC6FB6D</gtr:id><gtr:name>University of Heidelberg</gtr:name><gtr:address><gtr:line1>University of Heidelberg</gtr:line1><gtr:line4>Heidelberg</gtr:line4><gtr:postCode>D-69120</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/E4E1DAA0-8180-41F1-9351-540577DB2B5F"><gtr:id>E4E1DAA0-8180-41F1-9351-540577DB2B5F</gtr:id><gtr:name>Saarland University</gtr:name><gtr:address><gtr:line1>Main Campus</gtr:line1><gtr:line2>Stuhlsatzenhausweg</gtr:line2><gtr:postCode>D-66123</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C754D612-4D8B-42CB-922C-07E7F5BE4B49"><gtr:id>C754D612-4D8B-42CB-922C-07E7F5BE4B49</gtr:id><gtr:name>Washington University in St. Louis</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/9B520E8D-05F2-4A18-9EDF-C1503366E9E1"><gtr:id>9B520E8D-05F2-4A18-9EDF-C1503366E9E1</gtr:id><gtr:name>Eli Lilly &amp; Company Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/99A20F70-F6B7-43DE-94E4-7004FAE6291E"><gtr:id>99A20F70-F6B7-43DE-94E4-7004FAE6291E</gtr:id><gtr:name>Ludwig Maximilians University Munich</gtr:name><gtr:address><gtr:line1>Geschwister-Scholl-Platz 1</gtr:line1><gtr:postCode>D-80539</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/7B1A15D2-38E4-47E5-9E56-B54D2168A3F3"><gtr:id>7B1A15D2-38E4-47E5-9E56-B54D2168A3F3</gtr:id><gtr:name>UCL Institute of Neurology</gtr:name><gtr:address><gtr:line1>Queen Square</gtr:line1><gtr:city>London</gtr:city><gtr:postCode>WC1N 3BG</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/F3FA8702-BCB5-4A27-917C-5B072977CD7B"><gtr:id>F3FA8702-BCB5-4A27-917C-5B072977CD7B</gtr:id><gtr:name>Institute of Public Health Cambridge</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/CE562D3D-45D5-45B3-99FF-A81611187A1C"><gtr:id>CE562D3D-45D5-45B3-99FF-A81611187A1C</gtr:id><gtr:name>Veterinary Services</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/536F86BC-EBF8-4501-83B6-B6F27C65DC82"><gtr:id>536F86BC-EBF8-4501-83B6-B6F27C65DC82</gtr:id><gtr:name>Quest Diagnostics</gtr:name><gtr:address><gtr:line1>San Juan Capistrano</gtr:line1><gtr:postCode>CA 92690</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/F0DBAED0-29B0-4179-B59E-25AABE0E40AA"><gtr:id>F0DBAED0-29B0-4179-B59E-25AABE0E40AA</gtr:id><gtr:name>University of Cantabria</gtr:name><gtr:address><gtr:line1>Edificio de Filolog?a. Bajo</gtr:line1><gtr:line2>Avda de Los Castros S/N</gtr:line2><gtr:line4>Santander</gtr:line4><gtr:line5>Cantabria. E-39005</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3057A190-E37B-4791-9DEF-252CDFE3646B"><gtr:id>3057A190-E37B-4791-9DEF-252CDFE3646B</gtr:id><gtr:name>Faculty of Medical and Human Sciences</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/1971DE66-86B6-45D7-8CE0-39600A6FCCD6"><gtr:id>1971DE66-86B6-45D7-8CE0-39600A6FCCD6</gtr:id><gtr:name>Goethe University of Frankfurt am Main</gtr:name><gtr:address><gtr:line1>Max von Laue Str. 7</gtr:line1><gtr:line4>Frankfurt-am-Main</gtr:line4><gtr:postCode>60438</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/98C81591-CD71-45D3-916B-17A178772A77"><gtr:id>98C81591-CD71-45D3-916B-17A178772A77</gtr:id><gtr:name>Fondazione Santa Lucia</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/412B970D-5C3D-408C-A6E2-EA97667ABAE6"><gtr:id>412B970D-5C3D-408C-A6E2-EA97667ABAE6</gtr:id><gtr:name>Genetic and Environmental Risk in Alzheimer's Disease (GERAD)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/091A7281-194A-4C7B-8E9A-0CEB4FEE954B"><gtr:id>091A7281-194A-4C7B-8E9A-0CEB4FEE954B</gtr:id><gtr:name>Faculty of Medicine</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/EFBCA875-6122-4E05-A9E7-93AADEBB84FD"><gtr:id>EFBCA875-6122-4E05-A9E7-93AADEBB84FD</gtr:id><gtr:name>Genetic Architecture of Rate of Alzheimer?s Decline  (GENAROAD) Consortium</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/364AFA86-27AE-4629-85F5-5A26B737189E"><gtr:id>364AFA86-27AE-4629-85F5-5A26B737189E</gtr:id><gtr:name>Population Genetics Technologies Ltd</gtr:name><gtr:address><gtr:line1>Babraham Hall</gtr:line1><gtr:city>Babraham</gtr:city><gtr:postCode>CB22 3AT</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/598EC0B6-AEB9-4323-95F7-5B4EFCDDF33E"><gtr:id>598EC0B6-AEB9-4323-95F7-5B4EFCDDF33E</gtr:id><gtr:name>Friedrich-Alexander University</gtr:name><gtr:address><gtr:line1>Schlossplatz 4</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C3ED34B5-76A5-42E4-B75E-2BE513E68328"><gtr:id>C3ED34B5-76A5-42E4-B75E-2BE513E68328</gtr:id><gtr:name>University of Navarra</gtr:name><gtr:address><gtr:line1>Campus Universitario</gtr:line1><gtr:line4>E-31080 Pamplona</gtr:line4><gtr:line5>Navarra</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3CFB9490-9508-4E43-A019-042327F992A7"><gtr:id>3CFB9490-9508-4E43-A019-042327F992A7</gtr:id><gtr:name>Eisai Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/4A4090D5-D795-4C4B-8A6B-00D25830130F"><gtr:id>4A4090D5-D795-4C4B-8A6B-00D25830130F</gtr:id><gtr:name>University of Duisburg-Essen</gtr:name><gtr:address><gtr:line1>University of Duisburg-Essen</gtr:line1><gtr:line2>Geibelstrase 41</gtr:line2><gtr:line4>Duisburg</gtr:line4><gtr:line5>D-47057</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/F7233F24-93D3-40B6-A4C4-54222647E41F"><gtr:id>F7233F24-93D3-40B6-A4C4-54222647E41F</gtr:id><gtr:name>University of Bonn</gtr:name><gtr:address><gtr:line1>Katzenburgweg 5</gtr:line1><gtr:line4>Bonn</gtr:line4><gtr:line5>D-53115</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/1E990A7B-9400-4B6B-943F-E190AE5BA323"><gtr:id>1E990A7B-9400-4B6B-943F-E190AE5BA323</gtr:id><gtr:name>Arizona Association for Play Therapy (AZAPT)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/F9F1D136-12E3-4BE4-9668-0C9BC4A7C1BF"><gtr:id>F9F1D136-12E3-4BE4-9668-0C9BC4A7C1BF</gtr:id><gtr:name>Bangor University</gtr:name><gtr:address><gtr:line1>Bangor University</gtr:line1><gtr:line4>Bangor</gtr:line4><gtr:line5>Gwynedd</gtr:line5><gtr:postCode>LL57 2DG</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/97733DB9-75CC-45FF-9F14-A799FA918A46"><gtr:id>97733DB9-75CC-45FF-9F14-A799FA918A46</gtr:id><gtr:name>Jackson Laboratories</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/CAA19E42-1C7E-493A-92D7-A68B3E21FF55"><gtr:id>CAA19E42-1C7E-493A-92D7-A68B3E21FF55</gtr:id><gtr:name>Severnside Alliance for Translational Research (SARTRE)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D47BF37E-8CC8-4F3B-92D1-EB88BCFB3028"><gtr:id>D47BF37E-8CC8-4F3B-92D1-EB88BCFB3028</gtr:id><gtr:name>Cardiovascular Medicine</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/37CD2BEF-8A0E-4320-92D5-329AD0B2010D"><gtr:id>37CD2BEF-8A0E-4320-92D5-329AD0B2010D</gtr:id><gtr:name>Mayo Foundation for Medical Education and Research (MFMER)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/47977EA7-B9F8-4D02-9BD2-FD4D34F2644D"><gtr:id>47977EA7-B9F8-4D02-9BD2-FD4D34F2644D</gtr:id><gtr:name>Genomics England</gtr:name><gtr:address><gtr:line1>Queen Mary University of London</gtr:line1><gtr:line2>Dawson Hall</gtr:line2><gtr:line3>Charterhouse Square</gtr:line3><gtr:postCode>EC1M 6BQ</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/6305D1CE-8FA0-48D0-A970-411CC4569B99"><gtr:id>6305D1CE-8FA0-48D0-A970-411CC4569B99</gtr:id><gtr:name>Brigham Young University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/BA9BFCD1-C860-4387-B150-BD302EFE4049"><gtr:id>BA9BFCD1-C860-4387-B150-BD302EFE4049</gtr:id><gtr:name>Free University of Berlin</gtr:name><gtr:address><gtr:line1>Kaiserswerther Str. 16-18</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/622CACE1-DE8C-4EFF-B8A8-5F62E089B682"><gtr:id>622CACE1-DE8C-4EFF-B8A8-5F62E089B682</gtr:id><gtr:name>Neuroscience; IOP</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/71192811-F979-4E8C-BDA8-BAF2693176FB"><gtr:id>71192811-F979-4E8C-BDA8-BAF2693176FB</gtr:id><gtr:name>University of Lille</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/80C94FE7-08FC-4ED7-B8BC-CDACE706CF73"><gtr:id>80C94FE7-08FC-4ED7-B8BC-CDACE706CF73</gtr:id><gtr:name>JPND Research</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/8F8BCFC1-FF94-4796-B5E0-5A64B0C3AB6C"><gtr:id>8F8BCFC1-FF94-4796-B5E0-5A64B0C3AB6C</gtr:id><gtr:name>Autonomous University of Madrid</gtr:name><gtr:address><gtr:line1>Ciudad Universitaria de Cantoblanco</gtr:line1><gtr:line2>C/Francisco Tomas y Valiente, 1</gtr:line2><gtr:line4>Madrid</gtr:line4><gtr:line5>E-28049</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/65F4441E-11ED-426D-B373-5DE4963CCE1E"><gtr:id>65F4441E-11ED-426D-B373-5DE4963CCE1E</gtr:id><gtr:name>Hospital de Sant Pau</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/AB307619-D4FA-427E-A042-09DBEBA84669"><gtr:id>AB307619-D4FA-427E-A042-09DBEBA84669</gtr:id><gtr:name>Swansea University</gtr:name><gtr:address><gtr:line1>Singleton Park</gtr:line1><gtr:postCode>SA2 8PP</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/19185705-3FB8-4C9C-B8F4-D5D7EA64F57F"><gtr:id>19185705-3FB8-4C9C-B8F4-D5D7EA64F57F</gtr:id><gtr:name>National Center for Biotechnology Information (NCBI)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/B52848EB-6923-4123-A367-0D33966FD9FC"><gtr:id>B52848EB-6923-4123-A367-0D33966FD9FC</gtr:id><gtr:name>Albert-Ludwigs University Freiburg</gtr:name><gtr:address><gtr:line1>Albert-Ludwigs University</gtr:line1><gtr:line2>Werthmannplatz 1</gtr:line2><gtr:line3>D-79085 Freiburg1</gtr:line3><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/E3FF571C-4ECF-478A-AA19-5F68DA0D9627"><gtr:id>E3FF571C-4ECF-478A-AA19-5F68DA0D9627</gtr:id><gtr:name>University of Zurich</gtr:name><gtr:address><gtr:line1>71,Raemistrasse</gtr:line1><gtr:line4>Zurich</gtr:line4><gtr:line5>CH 8006</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/DCEC74AE-6E7C-40FC-BFCA-C52990BCEE56"><gtr:id>DCEC74AE-6E7C-40FC-BFCA-C52990BCEE56</gtr:id><gtr:name>School of Clinical Medicine</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/05F17A40-A0E2-4FF2-BC89-81C0CCE9A7D7"><gtr:id>05F17A40-A0E2-4FF2-BC89-81C0CCE9A7D7</gtr:id><gtr:name>Washington University at St Louis</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/844A3A42-4278-4EBF-BCDF-787569FA4AD3"><gtr:id>844A3A42-4278-4EBF-BCDF-787569FA4AD3</gtr:id><gtr:name>Research institute for neurodegerative diseases (DZNE)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/89DB4E4C-8508-44EF-A569-A38E0ED27CA8"><gtr:id>89DB4E4C-8508-44EF-A569-A38E0ED27CA8</gtr:id><gtr:name>University of Dublin</gtr:name><gtr:address><gtr:line1>University of Dublin</gtr:line1><gtr:line2>Trinity College</gtr:line2><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:department>School of Medicine</gtr:department><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A0F5FE7C-8820-488E-9121-EEA8CF4C6CF3"><gtr:id>A0F5FE7C-8820-488E-9121-EEA8CF4C6CF3</gtr:id><gtr:name>NIHR Oxford Biomedical Research Centre</gtr:name><gtr:address><gtr:line1>Botnar Research Centre</gtr:line1><gtr:line2>Nuffield Orthopaedic centre</gtr:line2><gtr:line3>Windmill Rd</gtr:line3><gtr:postCode>OX3 7LD</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D6237E81-EC70-49B1-881F-9E0645D5D590"><gtr:id>D6237E81-EC70-49B1-881F-9E0645D5D590</gtr:id><gtr:name>University of Oviedo</gtr:name><gtr:address><gtr:line1>University of Oviedo</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/FAE32A25-51D3-49EF-998F-281B3A47C212"><gtr:id>FAE32A25-51D3-49EF-998F-281B3A47C212</gtr:id><gtr:name>Helmholtz Association of German Research Centres</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/42B56A32-9194-468C-A790-BE55133838A6"><gtr:id>42B56A32-9194-468C-A790-BE55133838A6</gtr:id><gtr:name>University of Hamburg</gtr:name><gtr:address><gtr:line1>ZMK</gtr:line1><gtr:line2>Blunderstrasse</gtr:line2><gtr:line4>Hamburg</gtr:line4><gtr:line5>20146</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3B1E5961-8677-4A32-B15C-12FB968FA163"><gtr:id>3B1E5961-8677-4A32-B15C-12FB968FA163</gtr:id><gtr:name>University of Pennsylvania</gtr:name><gtr:address><gtr:line1>3451 Walnut Street,</gtr:line1><gtr:line2>Suite P-221</gtr:line2><gtr:line3>Franklin Building</gtr:line3><gtr:line4>Philadelphia</gtr:line4><gtr:postCode>PA 19104</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/6EA29FCF-7F5D-4187-B33F-25000D54809E"><gtr:id>6EA29FCF-7F5D-4187-B33F-25000D54809E</gtr:id><gtr:name>Department of Health Social Services and Public Safety (DHSSPS)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/007E0817-B05C-490A-B38A-2EDA79558DDD"><gtr:id>007E0817-B05C-490A-B38A-2EDA79558DDD</gtr:id><gtr:name>Boston University</gtr:name><gtr:address><gtr:line1>One Sherborn Street</gtr:line1><gtr:line2>Boston</gtr:line2><gtr:line3>Massachusetts</gtr:line3><gtr:line4>MA 02215</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4E67597F-C9AB-4ED2-BB87-FB1D1FC6FB6D"><gtr:id>4E67597F-C9AB-4ED2-BB87-FB1D1FC6FB6D</gtr:id><gtr:name>University of Heidelberg</gtr:name><gtr:address><gtr:line1>University of Heidelberg</gtr:line1><gtr:line4>Heidelberg</gtr:line4><gtr:postCode>D-69120</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/E4E1DAA0-8180-41F1-9351-540577DB2B5F"><gtr:id>E4E1DAA0-8180-41F1-9351-540577DB2B5F</gtr:id><gtr:name>Saarland University</gtr:name><gtr:address><gtr:line1>Main Campus</gtr:line1><gtr:line2>Stuhlsatzenhausweg</gtr:line2><gtr:postCode>D-66123</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C754D612-4D8B-42CB-922C-07E7F5BE4B49"><gtr:id>C754D612-4D8B-42CB-922C-07E7F5BE4B49</gtr:id><gtr:name>Washington University in St. Louis</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9B520E8D-05F2-4A18-9EDF-C1503366E9E1"><gtr:id>9B520E8D-05F2-4A18-9EDF-C1503366E9E1</gtr:id><gtr:name>Eli Lilly &amp; Company Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/99A20F70-F6B7-43DE-94E4-7004FAE6291E"><gtr:id>99A20F70-F6B7-43DE-94E4-7004FAE6291E</gtr:id><gtr:name>Ludwig Maximilians University Munich</gtr:name><gtr:address><gtr:line1>Geschwister-Scholl-Platz 1</gtr:line1><gtr:postCode>D-80539</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/7B1A15D2-38E4-47E5-9E56-B54D2168A3F3"><gtr:id>7B1A15D2-38E4-47E5-9E56-B54D2168A3F3</gtr:id><gtr:name>UCL Institute of Neurology</gtr:name><gtr:address><gtr:line1>Queen Square</gtr:line1><gtr:city>London</gtr:city><gtr:postCode>WC1N 3BG</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F3FA8702-BCB5-4A27-917C-5B072977CD7B"><gtr:id>F3FA8702-BCB5-4A27-917C-5B072977CD7B</gtr:id><gtr:name>Institute of Public Health Cambridge</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/CE562D3D-45D5-45B3-99FF-A81611187A1C"><gtr:id>CE562D3D-45D5-45B3-99FF-A81611187A1C</gtr:id><gtr:name>Veterinary Services</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/536F86BC-EBF8-4501-83B6-B6F27C65DC82"><gtr:id>536F86BC-EBF8-4501-83B6-B6F27C65DC82</gtr:id><gtr:name>Quest Diagnostics</gtr:name><gtr:address><gtr:line1>San Juan Capistrano</gtr:line1><gtr:postCode>CA 92690</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F0DBAED0-29B0-4179-B59E-25AABE0E40AA"><gtr:id>F0DBAED0-29B0-4179-B59E-25AABE0E40AA</gtr:id><gtr:name>University of Cantabria</gtr:name><gtr:address><gtr:line1>Edificio de Filolog?a. Bajo</gtr:line1><gtr:line2>Avda de Los Castros S/N</gtr:line2><gtr:line4>Santander</gtr:line4><gtr:line5>Cantabria. E-39005</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3057A190-E37B-4791-9DEF-252CDFE3646B"><gtr:id>3057A190-E37B-4791-9DEF-252CDFE3646B</gtr:id><gtr:name>Faculty of Medical and Human Sciences</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/1971DE66-86B6-45D7-8CE0-39600A6FCCD6"><gtr:id>1971DE66-86B6-45D7-8CE0-39600A6FCCD6</gtr:id><gtr:name>Goethe University of Frankfurt am Main</gtr:name><gtr:address><gtr:line1>Max von Laue Str. 7</gtr:line1><gtr:line4>Frankfurt-am-Main</gtr:line4><gtr:postCode>60438</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/98C81591-CD71-45D3-916B-17A178772A77"><gtr:id>98C81591-CD71-45D3-916B-17A178772A77</gtr:id><gtr:name>Fondazione Santa Lucia</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/412B970D-5C3D-408C-A6E2-EA97667ABAE6"><gtr:id>412B970D-5C3D-408C-A6E2-EA97667ABAE6</gtr:id><gtr:name>Genetic and Environmental Risk in Alzheimer's Disease (GERAD)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/091A7281-194A-4C7B-8E9A-0CEB4FEE954B"><gtr:id>091A7281-194A-4C7B-8E9A-0CEB4FEE954B</gtr:id><gtr:name>Faculty of Medicine</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/EFBCA875-6122-4E05-A9E7-93AADEBB84FD"><gtr:id>EFBCA875-6122-4E05-A9E7-93AADEBB84FD</gtr:id><gtr:name>Genetic Architecture of Rate of Alzheimer?s Decline  (GENAROAD) Consortium</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/364AFA86-27AE-4629-85F5-5A26B737189E"><gtr:id>364AFA86-27AE-4629-85F5-5A26B737189E</gtr:id><gtr:name>Population Genetics Technologies Ltd</gtr:name><gtr:address><gtr:line1>Babraham Hall</gtr:line1><gtr:city>Babraham</gtr:city><gtr:postCode>CB22 3AT</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/598EC0B6-AEB9-4323-95F7-5B4EFCDDF33E"><gtr:id>598EC0B6-AEB9-4323-95F7-5B4EFCDDF33E</gtr:id><gtr:name>Friedrich-Alexander University</gtr:name><gtr:address><gtr:line1>Schlossplatz 4</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C3ED34B5-76A5-42E4-B75E-2BE513E68328"><gtr:id>C3ED34B5-76A5-42E4-B75E-2BE513E68328</gtr:id><gtr:name>University of Navarra</gtr:name><gtr:address><gtr:line1>Campus Universitario</gtr:line1><gtr:line4>E-31080 Pamplona</gtr:line4><gtr:line5>Navarra</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3CFB9490-9508-4E43-A019-042327F992A7"><gtr:id>3CFB9490-9508-4E43-A019-042327F992A7</gtr:id><gtr:name>Eisai Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4A4090D5-D795-4C4B-8A6B-00D25830130F"><gtr:id>4A4090D5-D795-4C4B-8A6B-00D25830130F</gtr:id><gtr:name>University of Duisburg-Essen</gtr:name><gtr:address><gtr:line1>University of Duisburg-Essen</gtr:line1><gtr:line2>Geibelstrase 41</gtr:line2><gtr:line4>Duisburg</gtr:line4><gtr:line5>D-47057</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F7233F24-93D3-40B6-A4C4-54222647E41F"><gtr:id>F7233F24-93D3-40B6-A4C4-54222647E41F</gtr:id><gtr:name>University of Bonn</gtr:name><gtr:address><gtr:line1>Katzenburgweg 5</gtr:line1><gtr:line4>Bonn</gtr:line4><gtr:line5>D-53115</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/1E990A7B-9400-4B6B-943F-E190AE5BA323"><gtr:id>1E990A7B-9400-4B6B-943F-E190AE5BA323</gtr:id><gtr:name>Arizona Association for Play Therapy (AZAPT)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F9F1D136-12E3-4BE4-9668-0C9BC4A7C1BF"><gtr:id>F9F1D136-12E3-4BE4-9668-0C9BC4A7C1BF</gtr:id><gtr:name>Bangor University</gtr:name><gtr:address><gtr:line1>Bangor University</gtr:line1><gtr:line4>Bangor</gtr:line4><gtr:line5>Gwynedd</gtr:line5><gtr:postCode>LL57 2DG</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/97733DB9-75CC-45FF-9F14-A799FA918A46"><gtr:id>97733DB9-75CC-45FF-9F14-A799FA918A46</gtr:id><gtr:name>Jackson Laboratories</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/CAA19E42-1C7E-493A-92D7-A68B3E21FF55"><gtr:id>CAA19E42-1C7E-493A-92D7-A68B3E21FF55</gtr:id><gtr:name>Severnside Alliance for Translational Research (SARTRE)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D47BF37E-8CC8-4F3B-92D1-EB88BCFB3028"><gtr:id>D47BF37E-8CC8-4F3B-92D1-EB88BCFB3028</gtr:id><gtr:name>Cardiovascular Medicine</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/37CD2BEF-8A0E-4320-92D5-329AD0B2010D"><gtr:id>37CD2BEF-8A0E-4320-92D5-329AD0B2010D</gtr:id><gtr:name>Mayo Foundation for Medical Education and Research (MFMER)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/47977EA7-B9F8-4D02-9BD2-FD4D34F2644D"><gtr:id>47977EA7-B9F8-4D02-9BD2-FD4D34F2644D</gtr:id><gtr:name>Genomics England</gtr:name><gtr:address><gtr:line1>Queen Mary University of London</gtr:line1><gtr:line2>Dawson Hall</gtr:line2><gtr:line3>Charterhouse Square</gtr:line3><gtr:postCode>EC1M 6BQ</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/6305D1CE-8FA0-48D0-A970-411CC4569B99"><gtr:id>6305D1CE-8FA0-48D0-A970-411CC4569B99</gtr:id><gtr:name>Brigham Young University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/BA9BFCD1-C860-4387-B150-BD302EFE4049"><gtr:id>BA9BFCD1-C860-4387-B150-BD302EFE4049</gtr:id><gtr:name>Free University of Berlin</gtr:name><gtr:address><gtr:line1>Kaiserswerther Str. 16-18</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/622CACE1-DE8C-4EFF-B8A8-5F62E089B682"><gtr:id>622CACE1-DE8C-4EFF-B8A8-5F62E089B682</gtr:id><gtr:name>Neuroscience; IOP</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/71192811-F979-4E8C-BDA8-BAF2693176FB"><gtr:id>71192811-F979-4E8C-BDA8-BAF2693176FB</gtr:id><gtr:name>University of Lille</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/80C94FE7-08FC-4ED7-B8BC-CDACE706CF73"><gtr:id>80C94FE7-08FC-4ED7-B8BC-CDACE706CF73</gtr:id><gtr:name>JPND Research</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/8F8BCFC1-FF94-4796-B5E0-5A64B0C3AB6C"><gtr:id>8F8BCFC1-FF94-4796-B5E0-5A64B0C3AB6C</gtr:id><gtr:name>Autonomous University of Madrid</gtr:name><gtr:address><gtr:line1>Ciudad Universitaria de Cantoblanco</gtr:line1><gtr:line2>C/Francisco Tomas y Valiente, 1</gtr:line2><gtr:line4>Madrid</gtr:line4><gtr:line5>E-28049</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/65F4441E-11ED-426D-B373-5DE4963CCE1E"><gtr:id>65F4441E-11ED-426D-B373-5DE4963CCE1E</gtr:id><gtr:name>Hospital de Sant Pau</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/AB307619-D4FA-427E-A042-09DBEBA84669"><gtr:id>AB307619-D4FA-427E-A042-09DBEBA84669</gtr:id><gtr:name>Swansea University</gtr:name><gtr:address><gtr:line1>Singleton Park</gtr:line1><gtr:postCode>SA2 8PP</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/19185705-3FB8-4C9C-B8F4-D5D7EA64F57F"><gtr:id>19185705-3FB8-4C9C-B8F4-D5D7EA64F57F</gtr:id><gtr:name>National Center for Biotechnology Information (NCBI)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/B52848EB-6923-4123-A367-0D33966FD9FC"><gtr:id>B52848EB-6923-4123-A367-0D33966FD9FC</gtr:id><gtr:name>Albert-Ludwigs University Freiburg</gtr:name><gtr:address><gtr:line1>Albert-Ludwigs University</gtr:line1><gtr:line2>Werthmannplatz 1</gtr:line2><gtr:line3>D-79085 Freiburg1</gtr:line3><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/E3FF571C-4ECF-478A-AA19-5F68DA0D9627"><gtr:id>E3FF571C-4ECF-478A-AA19-5F68DA0D9627</gtr:id><gtr:name>University of Zurich</gtr:name><gtr:address><gtr:line1>71,Raemistrasse</gtr:line1><gtr:line4>Zurich</gtr:line4><gtr:line5>CH 8006</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DCEC74AE-6E7C-40FC-BFCA-C52990BCEE56"><gtr:id>DCEC74AE-6E7C-40FC-BFCA-C52990BCEE56</gtr:id><gtr:name>School of Clinical Medicine</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/05F17A40-A0E2-4FF2-BC89-81C0CCE9A7D7"><gtr:id>05F17A40-A0E2-4FF2-BC89-81C0CCE9A7D7</gtr:id><gtr:name>Washington University at St Louis</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/844A3A42-4278-4EBF-BCDF-787569FA4AD3"><gtr:id>844A3A42-4278-4EBF-BCDF-787569FA4AD3</gtr:id><gtr:name>Research institute for neurodegerative diseases (DZNE)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/89DB4E4C-8508-44EF-A569-A38E0ED27CA8"><gtr:id>89DB4E4C-8508-44EF-A569-A38E0ED27CA8</gtr:id><gtr:name>University of Dublin</gtr:name><gtr:address><gtr:line1>University of Dublin</gtr:line1><gtr:line2>Trinity College</gtr:line2><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/31306DBD-0EEB-4684-9CA0-B35B5C0B52F1"><gtr:id>31306DBD-0EEB-4684-9CA0-B35B5C0B52F1</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Owen</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/A64B614B-387F-4A87-8F08-18C3C2916676"><gtr:id>A64B614B-387F-4A87-8F08-18C3C2916676</gtr:id><gtr:firstName>Julie</gtr:firstName><gtr:surname>Williams</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/B09A5C71-5A14-44F8-A31B-7638568AD228"><gtr:id>B09A5C71-5A14-44F8-A31B-7638568AD228</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>Holmans</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/85D807DF-0780-4EA3-B61C-036EBF025B49"><gtr:id>85D807DF-0780-4EA3-B61C-036EBF025B49</gtr:id><gtr:firstName>Huw</gtr:firstName><gtr:otherNames>R</gtr:otherNames><gtr:surname>Morris</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/9553B924-A6AB-4C31-9B20-581368AE6259"><gtr:id>9553B924-A6AB-4C31-9B20-581368AE6259</gtr:id><gtr:firstName>Meng</gtr:firstName><gtr:surname>Li</gtr:surname><gtr:orcidId>0000-0002-4803-4643</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/D1E5CC8B-6A3D-41BE-80F2-4319727287D3"><gtr:id>D1E5CC8B-6A3D-41BE-80F2-4319727287D3</gtr:id><gtr:firstName>Valentina</gtr:firstName><gtr:surname>Escott-Price</gtr:surname><gtr:orcidId>0000-0003-1784-5483</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/75B118A8-564B-4AC5-8C39-960C3B0F161C"><gtr:id>75B118A8-564B-4AC5-8C39-960C3B0F161C</gtr:id><gtr:firstName>Denise</gtr:firstName><gtr:surname>Harold</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/B1FE4EBC-AF3A-4AE4-A2ED-4BD58E1E2544"><gtr:id>B1FE4EBC-AF3A-4AE4-A2ED-4BD58E1E2544</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:otherNames>Conlon</gtr:otherNames><gtr:surname>O'Donovan</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/80801A9C-4D2F-4FE7-9950-3443CCC8B8CC"><gtr:id>80801A9C-4D2F-4FE7-9950-3443CCC8B8CC</gtr:id><gtr:firstName>Jade</gtr:firstName><gtr:surname>Chapman</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=MR%2FK013041%2F1"><gtr:id>0F500090-2890-4C54-BC2A-394D5155E1DC</gtr:id><gtr:title>Further defining the genetic architecture of Alzheimer's disease</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/K013041/1</gtr:grantReference><gtr:abstractText>Alzheimer's disease is a common debilitating disorder which affects individuals, families and communities. Just under half a million people have Alzheimer's disease (AD) in the UK with an estimated cost of &amp;pound;23 billion per year. It is also estimated that the numbers with AD will double in the next generation. It is vital we understand what causes this disease and develop therapies to prevent, delay and treat it. Finding genes which affect the development of AD is an important means to pinpoint processes that are going wrong and contributing to the death of brain cells, which characterises this disease and underlies the symptoms of memory loss and general cognitive degeneration. Over the last 25 years approximately a quarter of the genetic contributors to disease have been identified and our group have played a pivotal role in this and have recently discovered 8 of the 10 common risk variants for AD. This has made us re-think some of our ideas about the specific processes which contribute to disease. These genes cluster together to form groups, implicating processes like our immune response, how we process lipids like cholesterol in the brain and a specific process called endocytosis, which brings large molecules into cells and affects their transport within cells, such as neurons. But over half the genetic contribution to disease is yet to be found. We propose a programme of research which builds on our current strengths, focusing on identifying rare genetic variants of moderate to strong effect observed in the coding regions of genes. We will perform a large, powerful study in which we compare 300,000 DNA variants from throughout the human genome, in 20,000 AD cases and 49,000 controls. Through sample collection and collaboration, we will enrich our clinical samples to include 1000 individuals with early onset AD. This group are more likely to have rare genetic changes of moderate to large effect on their development of disease. This experiment has an excellent chace of identifying new risk genes for AD and producing targets better suited to model disease in human cells and produce new therapeutics. We will also facilitate future research by producing a bio-bank of cell lines suitable for human modelling of disease using the latest stem cell technology (inducible pluripotent stem cells: iPSC) and making this available to the research community and pharmaceutical companies.</gtr:abstractText><gtr:technicalSummary>Approximately half a million people have Alzheimer's disease (AD) in the UK, incurring an annual care cost of &amp;pound;23 billion. 35 million have dementia world-wide and it is estimated that these numbers will double by 2040. Identifying genes that affect the development of AD is important in pin-pointing potential disease mechanisms, testing new therapeutics and in predicting individual risk of disease development. Our programme of research will focus on identifying rare, exonic susceptibility variants of moderate/strong effect, using novel, powerful, genome-wide approaches and extended and enriched clinical samples. We will undertake a case-control association study comprising 20,000 AD cases and 49,000 controls focusing on coding regions throughout the genome, using the Illumina exome chip. We will also collect a sample of 500 cases with early-onset AD (EOAD), an uncommon form of the disease (&amp;lt;5% cases) that manifests before the age of 65, and in which heritability is especially high (92-100%). We will sequence the exomes of the 500 EOAD individuals and analyse them together with 500 EOAD exomes available to us through collaboration. Susceptibility variants identified will be replicated in an independent sample of 10,000 AD cases and 10,000 controls. We aim to detect rare variants of larger effect than those observed for common susceptibility variants; these effects should prove easier to model and will facilitate the further understanding of disease mechanisms and the development of new therapeutics. We will combine all genetic data we have generated to extend and develop complex analyses including pathway analysis, sub-phenotypic analysis and cross-disease analysis. Finally, we will establish and extend research resources such as DNA and additional sample banking from all EOAD cases collected, and iPSC programmable cell lines from 50 EOAD cases to facilitate functional analyses. This resource will be made available to research and pharmaceutical communities.</gtr:technicalSummary><gtr:potentialImpactText>The ultimate aim of this research is to build a better understanding of the causes of Alzheimer's disease and in so doing, provide a platform for the development of targeted treatments and preventions. Thus the main potential beneficiaries are those with the disease and those at risk of developing the disease. AD has a high impact on society. The cost of caring for individuals with the disease is around &amp;pound;23billion per year, with a substantial component due to the social cost of funding practical care and the cost to society of losing skilled family members from the workforce, who care for relatives directly. Thus AD affects more than just the individuals diagnosed. It affects the family and the wider community. We know that the number of people with AD will double in the next generation, so this problem is getting worse. The timescale on identifying new drug targets and translating this into the clinic is typically 10-15 years.
Another potential impact of our research is in characterising individual risk profiles, which could be useful in improving the efficiency of clinical trials. For example, a particular drug under trial could be more beneficial for those with one type of risk profile compared to others. Therefore, defining the variation in these profiles could aid more efficient clinical trials, resulting in increased numbers and better, targeted drugs coming to clinic. This could potentially have a considerable economic impact for the pharmaceutical sector. Most drugs fail to get through clinical trials, producing an enormous cost burden for pharmaceutical companies. We are working with pharmaceutical and other commercial companies to produce a test of genetic risk for use in clinical trials and are confident that this could be commercially available in the next couple of years.
As we further define the genetic architecture of AD, predicting one's risk of developing disease will become a more realistic outcome. Currently, genetic testing is only helpful for hose with known autosomal dominant mutations. This programme is likely to result in several new variants of moderate to strong effect, which may also be used to predict disease in others. The timeline for this impact would be within the next 5 years.
Current animal and cellular models of AD have major limitations. This programme aims to identify genetic variants that have moderate to strong individual effects on disease development. Not only will these provide better animal models than the common risk variants identified so far, but will allow multiple genes to influence models, which may better reflect essential disease components. Currently, most mouse models based upon known disease mutations do not recapitulate the full range of disease symptoms. As we discover more genuine disease causing/risk variants, our ability to produce more realistic disease models will improve. This is likely to have significant impact on the success of commercial testing of new drugs by providing more accurate models. Mouse models could be available within a year of discovery and will be facilitated by our current funded collaborations- Neuromouse funded by the MRC.
In addition, iPSC models that reflect specific genetic risk profiles will be available to the research and commercial communities, directly from this research. This will provide relevant human cellular models to facilitate translation and be available during the course of the grant.
We also aim to identify genes that affect symptoms/characteristics of AD, such as psychosis, depression and rate of decline, which again can be used to target specific disease mechanisms through drug therapy. Similarly, we will test for common disease variants across diseases such as ALS, PD, cardiovascular disease and diabetes. These findings may be used to support drug development for the prevention of or treatment for individuals with or at risk of developing a broad range of diseases. Timelines of 10-15 years, as described above.</gtr:potentialImpactText><gtr:fund><gtr:end>2018-08-28</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-08-29</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2739222</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Center for Biotechnology Information (NCBI)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Genome-wide Association Study Collaboration</gtr:department><gtr:description>Genome-wide Association Studies</gtr:description><gtr:id>C56D1593-066F-4EB5-A69A-BF046973D88B</gtr:id><gtr:impact>The study, published in Nature Genetics (PubMed ID 19734902), has uncovered two new genes associated with Alzheimer's disease. Previously only one gene, APOE4, had been shown to be a risk factor for Alzheimer's disease. The study reveals, for the first time, that two further genes, CLU and PICALM, are related to Alzheimer's disease. This has led to worldwide media coverage. The data produced is still used in new studies with requests coming in to the host institution every few weeks.</gtr:impact><gtr:partnerContribution>This group of 45 collaborators all contributed towards the centres Genome-wide association study</gtr:partnerContribution><gtr:piContribution>Led and co-ordinated the study that involved the work of the following collaborators:
1 MRC Centre for Neuropsychiatric Genetics and Genomics, Department of Psychological Medicine and Neurology, School of Medicine, Cardiff University, Cardiff CF14 4XN, UK.
2 NIHR Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, Kings College, London, UK.
3 Department of Neuroscience, Institute of Psychiatry, Kings College, London, UK.
4 Institute of Public Health, University of Cambridge, Cambridge, UK.
5 Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.
6 Mercer's Institute for Research on Aging, St. James Hospital and Trinity College, Dublin, Ireland.
7 Institute of Genetics, Queen's Medical Centre, University of Nottingham, NG7 2UH, UK.
8 Ageing Group, Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, UK.
9 Division of Clinical Neurosciences, School of Medicine, University of Southampton, Southampton, UK.
10 Clinical Neuroscience Research Group, Greater Manchester Neurosciences Centre, University of Manchester, Salford, UK.
11 Oxford Project to Investigate Memory and Ageing (OPTIMA), University of Oxford, Level 4, John Radcliffe Hospital, Oxford OX3 9DU, UK.
12 Dementia Research Group, University of Bristol Institute of Clinical Neurosciences, Frenchay Hospital, Bristol, UK.
13 Department of Molecular Neuroscience and Reta Lilla Weston Laboratories, Institute of Neurology, London, UK.
14 MRC Prion Unit, Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK.
15 Dementia Research Centre, Department of Neurodegenerative Diseases, University College London, Institute of Neurology, London, UK.
16 Department of Psychiatry, University of Bonn, Sigmund-Freud-Str. 25, D-53105 Bonn, Germany.
17 Institute of Primary Medical Care, University Medical Center Hamburg-Eppendorf, Germany.
18 Department of Psychiatry, Charit&amp;eacute; Berlin, Germany.
19 Department of Psychiatry and Psychotherapy, University of Erlangen-N&amp;uuml;remberg, Germany.
20 LVR-Hospital Essen, Department of Psychiatry and Psychotherapy, University Duisburg-Essen, Germany.
21 Institute for Stroke and Dementia Reserach, Klinikum der Universit&amp;auml;t M&amp;uuml;nchen, Marchioninistr. 15, 81377, Munich, Germany.
22 Department of Neurology, Klinikum der Universit&amp;auml;t M&amp;uuml;nchen, Marchioninistr. 15, 81377, Munich, Germany.
23 Department of Geriatric Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Square J5, D-68161 Mannheim, Germany.
24 Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neuroscience, Laboratory of Neuroimaging &amp;amp; Biomarker Research, Trinity College, University of Dublin, Ireland.
25 Alzheimer Memorial Center and Geriatric Psychiatry Branch, Department of Psychiatry, Ludwig-Maximilian University, Munich, Germany.
26 Centre for Geriatric Medicine and Section of Gerontopsychiatry and Neuropsychology, Medical School, University of Freiburg, Germany.
27 Departments of Psychiatry, Neurology and Genetics, Washington University School of Medicine, St Louis, MO 63110, US.
28 Department of Biology, Brigham Young University, Provo, UT, 84602, USA.
29 Neurodegenerative Brain Diseases group, Department of Molecular Genetics, VIB, Antwerpen, Belgium.
30 Institute Born-Bunge and University of Antwerp; Antwerpen, Belgium.
31 Memory Clinic and Department of Neurology, ZNA Middelheim, Antwerpen, Belgium.
32 Department of Mental Health Sciences, University College London, UK.
33 The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
34 MRC Centre for Neurodegeneration Research, Department of Clinical Neuroscience, King's College London, Institute of Psychiatry, London, SE5 8AF, UK.
35 3rd Department of Neurology, Aristotle University of Thessaloniki, Thessaloniki, Greece.
36 Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, 20892, USA.
37 Department of Genomics, Life &amp;amp; Brain Center, University of Bonn, Sigmund-Freud-Str. 25, D-53127 Bonn, Germany.
38 Institute of Human Genetics, University of Bonn, Wilhelmstr. 31, D-53111 Bonn, Germany.
39 Institute for Medical Informatics, Biometry and Epidemiology, University Hospital of Essen, University Duisburg-Essen, Hufelandstr. 55, D-45147 Essen, Germany.
40 Institute of Epidemiology, Helmholtz Zentrum M&amp;uuml;nchen, German Research Center for Environmental Health, 85764 Neuherberg, Germany.
41 Institute of Medical Informatics, Biometry and Epidemiology, Chair of Epidemiology, Ludwig-Maximilians-Universit&amp;auml;t, Munich, Germany.
42 Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida 32224, USA.
43 Division of Biomedical Statistics and Informatics, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cardiff University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cardiff University School of Medicine</gtr:department><gtr:description>Translating the effects of new susceptibility genes for AD into disease mechanisms and potential drug screening</gtr:description><gtr:id>0F10258A-9CE8-42E2-A0BB-C192E89D9CB0</gtr:id><gtr:impact>unknown</gtr:impact><gtr:partnerContribution>Functional expertise, study design, co-supervision of research fellow Amy Gerrish</gtr:partnerContribution><gtr:piContribution>AD expertise, genotying, data analysis, study design, co-supervision of research fellow Amy Gerrish</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Department of Health Social Services and Public Safety (DHSSPS)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>UKDP</gtr:description><gtr:id>246C1B33-E1A4-4E16-9978-5CEF9F3E3711</gtr:id><gtr:impact>none yet</gtr:impact><gtr:partnerContribution>sample collections / cohorts, data and molecular biology</gtr:partnerContribution><gtr:piContribution>Biostatistical analysis and epidemiological</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Public Health Cambridge</gtr:department><gtr:description>GERAD (Genetic and Environmental Risk in Alzheimer's Disease)</gtr:description><gtr:id>58347DC0-BF7B-40D5-B30A-06352840AE7D</gtr:id><gtr:impact>Publications: PMED IDs: 19734902; 20862329; 20460622, 21085570, 22005930, 22027014, 21220680, 21460840, 20029910, 22445811, 22693153, 21812096, 22442439, 22430674, 22405046, 23150934</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, GWAS data from AD cases and/or controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leadership, management, DNA from AD cases &amp;amp; controls, Data analysis, directs study design &amp;amp; joint papers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Genetic Architecture of Rate of Alzheimer?s Decline  (GENAROAD) Consortium</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>GENAROAD</gtr:description><gtr:id>CAC2888E-6BD6-4B83-808B-4F19E71A9237</gtr:id><gtr:impact>none yet, paper being prepared for publication</gtr:impact><gtr:partnerContribution>data analysis</gtr:partnerContribution><gtr:piContribution>data and analyses</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Dublin</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:department>Trinity College Dublin</gtr:department><gtr:description>GERAD (Genetic and Environmental Risk in Alzheimer's Disease)</gtr:description><gtr:id>7932E403-A232-45AB-8F4B-88BE4BD3B2B9</gtr:id><gtr:impact>Publications: PMED IDs: 19734902; 20862329; 20460622, 21085570, 22005930, 22027014, 21220680, 21460840, 20029910, 22445811, 22693153, 21812096, 22442439, 22430674, 22405046, 23150934</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, GWAS data from AD cases and/or controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leadership, management, DNA from AD cases &amp;amp; controls, Data analysis, directs study design &amp;amp; joint papers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Oxford Parkinson's Disease Centre (OPDC)</gtr:department><gtr:description>Brains for Dementia Research</gtr:description><gtr:id>9E67A3D8-9629-4BEA-BC93-24966AEF1F1F</gtr:id><gtr:impact>BDR aims to set a gold standard for brain donation by coordinating brain banks across the country and providing high quality tissue to researchers.

We hope to enable more people to get involved in brain donation, thus boosting the number of brains available for this important research.

BDR is unique because every brain donor is monitored throughout their later life. This means that a complete medical history is available to accompany their donated brain tissue. This is crucial to allow researchers to make the most of donated tissue.

BDR run an online database of brain tissue. Researchers can search the database and apply to BDR for samples.</gtr:impact><gtr:partnerContribution>Overall Management of BDR Centre, recruitment and Brain Banking</gtr:partnerContribution><gtr:piContribution>Overall Management of BDR Centre, recruitment and Brain Banking</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cantabria</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:description>GERAD Exome Chip Consortium</gtr:description><gtr:id>229D9EFA-8756-4649-A7B1-32BF7E6EE952</gtr:id><gtr:impact>Exome chip paper replication on just under 90k subjects is in preparation (submitted to Nature Genetics Letters).</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, access to exome chip data from population controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leads the (GERAD) consortium, management, DNA from AD cases and controls, access to exome chip data from elderly, screened controls, data ananlysis, directs study design</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Sciences Division</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Physiology, Anatomy and Genetics</gtr:department><gtr:description>UK biobank neurodenerative disease platform</gtr:description><gtr:id>FEF1AD2A-1CC7-4C69-827F-E58539341207</gtr:id><gtr:impact>Grant application currently under review</gtr:impact><gtr:partnerContribution>co-investigators on grant application</gtr:partnerContribution><gtr:piContribution>Named investigator on grant application</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Duisburg-Essen</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>GERAD (Genetic and Environmental Risk in Alzheimer's Disease)</gtr:description><gtr:id>9B9F24A6-94E3-4D76-A367-3FAECF35A978</gtr:id><gtr:impact>Publications: PMED IDs: 19734902; 20862329; 20460622, 21085570, 22005930, 22027014, 21220680, 21460840, 20029910, 22445811, 22693153, 21812096, 22442439, 22430674, 22405046, 23150934</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, GWAS data from AD cases and/or controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leadership, management, DNA from AD cases &amp;amp; controls, Data analysis, directs study design &amp;amp; joint papers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Prion Unit and the Dementia Research Centre</gtr:department><gtr:description>GERAD (Genetic and Environmental Risk in Alzheimer's Disease)</gtr:description><gtr:id>CE0E9721-6EDF-47B6-B351-9FBB6E7F58AE</gtr:id><gtr:impact>Publications: PMED IDs: 19734902; 20862329; 20460622, 21085570, 22005930, 22027014, 21220680, 21460840, 20029910, 22445811, 22693153, 21812096, 22442439, 22430674, 22405046, 23150934</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, GWAS data from AD cases and/or controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leadership, management, DNA from AD cases &amp;amp; controls, Data analysis, directs study design &amp;amp; joint papers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>School of Biology Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Genetics and Genomics</gtr:department><gtr:description>GERAD Exome Chip Consortium</gtr:description><gtr:id>97B7B60B-1CD6-4EF5-9DBE-44DE521601E9</gtr:id><gtr:impact>Exome chip paper replication on just under 90k subjects is in preparation (submitted to Nature Genetics Letters).</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, access to exome chip data from population controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leads the (GERAD) consortium, management, DNA from AD cases and controls, access to exome chip data from elderly, screened controls, data ananlysis, directs study design</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Epidemiology</gtr:department><gtr:description>EPAD</gtr:description><gtr:id>0AB33298-5B41-4625-8004-BEEBDB83DA62</gtr:id><gtr:impact>none yet</gtr:impact><gtr:partnerContribution>cohorts, biomarker studies, epidemiological studies, random control studies</gtr:partnerContribution><gtr:piContribution>GENOTYPING AND ANALYSIS</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cardiff University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cardiff University School of Medicine</gtr:department><gtr:description>Eli Lilly Collaboration</gtr:description><gtr:id>FC28AC13-15A4-47AE-9489-0949AD076433</gtr:id><gtr:impact>unknown</gtr:impact><gtr:partnerContribution>scientific input, co-direct study design, funding</gtr:partnerContribution><gtr:piContribution>Access to patient bio-samples, co-directs study design</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Clinical Neuroscience</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Brains for Dementia Research</gtr:description><gtr:id>4963FC63-2817-4062-924D-BD6523C6207A</gtr:id><gtr:impact>BDR aims to set a gold standard for brain donation by coordinating brain banks across the country and providing high quality tissue to researchers.

We hope to enable more people to get involved in brain donation, thus boosting the number of brains available for this important research.

BDR is unique because every brain donor is monitored throughout their later life. This means that a complete medical history is available to accompany their donated brain tissue. This is crucial to allow researchers to make the most of donated tissue.

BDR run an online database of brain tissue. Researchers can search the database and apply to BDR for samples.</gtr:impact><gtr:partnerContribution>Overall Management of BDR Centre, recruitment and Brain Banking</gtr:partnerContribution><gtr:piContribution>Overall Management of BDR Centre, recruitment and Brain Banking</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Friedrich-Alexander University Erlangen-Nuremberg</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Department of Psychiatry</gtr:department><gtr:description>GERAD (Genetic and Environmental Risk in Alzheimer's Disease)</gtr:description><gtr:id>42E93FB0-6977-48D3-BAB0-E67C5C753879</gtr:id><gtr:impact>Publications: PMED IDs: 19734902; 20862329; 20460622, 21085570, 22005930, 22027014, 21220680, 21460840, 20029910, 22445811, 22693153, 21812096, 22442439, 22430674, 22405046, 23150934</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, GWAS data from AD cases and/or controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leadership, management, DNA from AD cases &amp;amp; controls, Data analysis, directs study design &amp;amp; joint papers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>School of Clinical Medicine</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Medical Genetics</gtr:department><gtr:description>MRC AD Cohort</gtr:description><gtr:id>B9095BBA-B8A1-494D-A81D-59880039532A</gtr:id><gtr:impact>16970641 17322133 17530621 17440948 17440933 17373700 17999207 18163421</gtr:impact><gtr:partnerContribution>The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.
The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.
The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.</gtr:partnerContribution><gtr:piContribution>We contributed DNA, clinical follow up information, genotyping and other laboratory work and complex data analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Using worms and flies to screen human genes associated with Alzheimer's disease</gtr:description><gtr:id>C7B77D94-C762-40A1-9708-8D1CF46FDBDE</gtr:id><gtr:impact>unknown</gtr:impact><gtr:partnerContribution>Functional expertise, Model organisms</gtr:partnerContribution><gtr:piContribution>AD expertise, GWAS data</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Developmental Neurobiology</gtr:department><gtr:description>MRC AD Cohort</gtr:description><gtr:id>A7E3203C-8D9F-4C49-8BBE-FCF35FA42566</gtr:id><gtr:impact>16970641 17322133 17530621 17440948 17440933 17373700 17999207 18163421</gtr:impact><gtr:partnerContribution>The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.
The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.
The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.</gtr:partnerContribution><gtr:piContribution>We contributed DNA, clinical follow up information, genotyping and other laboratory work and complex data analysis.</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Lille</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>International Genomics of Alzheimer's Project (IGAP)</gtr:description><gtr:id>BD1A2544-8C16-4C14-81A4-E71E301EDCE6</gtr:id><gtr:impact>papers in progress</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, GWAS data from AD cases and/or controls, input into study design, input into manuscript preparation, data analysis</gtr:partnerContribution><gtr:piContribution>Co-leadership, management, DNA from AD cases and controls, GWAS data from AD cases and controls, data analysis and joint papers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Using worms and flies to screen human genes associated with Alzheimer's disease</gtr:description><gtr:id>DB29AF9A-5554-4977-AED0-4A291B520DFE</gtr:id><gtr:impact>unknown</gtr:impact><gtr:partnerContribution>Functional expertise, Model organisms</gtr:partnerContribution><gtr:piContribution>AD expertise, GWAS data</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Swansea University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>CADR</gtr:description><gtr:id>0BC00941-A1AD-45E1-98DC-D44B4382F7E2</gtr:id><gtr:impact>none yet</gtr:impact><gtr:partnerContribution>data analysis, sample collections</gtr:partnerContribution><gtr:piContribution>sample preparation, data analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Helmholtz Association of German Research Centres</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>German Research Centre for Environmental Health</gtr:department><gtr:description>GERAD (Genetic and Environmental Risk in Alzheimer's Disease)</gtr:description><gtr:id>50124028-8E12-4A40-97BC-E9F23ACCA1EE</gtr:id><gtr:impact>Publications: PMED IDs: 19734902; 20862329; 20460622, 21085570, 22005930, 22027014, 21220680, 21460840, 20029910, 22445811, 22693153, 21812096, 22442439, 22430674, 22405046, 23150934</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, GWAS data from AD cases and/or controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leadership, management, DNA from AD cases &amp;amp; controls, Data analysis, directs study design &amp;amp; joint papers</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Dementia Research Centre (DRC)</gtr:department><gtr:description>UK biobank neurodenerative disease platform</gtr:description><gtr:id>8008F6C1-40C2-47B6-B68C-9D5995AAF695</gtr:id><gtr:impact>Grant application currently under review</gtr:impact><gtr:partnerContribution>co-investigators on grant application</gtr:partnerContribution><gtr:piContribution>Named investigator on grant application</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Bangor University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>CFAS</gtr:description><gtr:id>2082EC2F-DA3B-4206-B05F-48735157D71A</gtr:id><gtr:impact>CFAS prepared for Genetic analysis</gtr:impact><gtr:partnerContribution>Provided cohort</gtr:partnerContribution><gtr:piContribution>We are working together with CFAS to prepare the 3,000 participant cohort for genetic research.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Faculty of Medicine</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Clinical and Experimental Sciences</gtr:department><gtr:description>GERAD Exome Chip Consortium</gtr:description><gtr:id>FE94B109-DF1B-4FCB-AC91-B543A88A6F59</gtr:id><gtr:impact>Exome chip paper replication on just under 90k subjects is in preparation (submitted to Nature Genetics Letters).</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, access to exome chip data from population controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leads the (GERAD) consortium, management, DNA from AD cases and controls, access to exome chip data from elderly, screened controls, data ananlysis, directs study design</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Bangor University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>CADR</gtr:description><gtr:id>AB86F884-801B-4CA9-B43C-C6C92CAA70EC</gtr:id><gtr:impact>none yet</gtr:impact><gtr:partnerContribution>data analysis, sample collections</gtr:partnerContribution><gtr:piContribution>sample preparation, data analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bonn</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Department of Psychiatry</gtr:department><gtr:description>GERAD (Genetic and Environmental Risk in Alzheimer's Disease)</gtr:description><gtr:id>09CCA2EC-6EFF-4F4B-B8F4-C2AA707B0884</gtr:id><gtr:impact>Publications: PMED IDs: 19734902; 20862329; 20460622, 21085570, 22005930, 22027014, 21220680, 21460840, 20029910, 22445811, 22693153, 21812096, 22442439, 22430674, 22405046, 23150934</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, GWAS data from AD cases and/or controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leadership, management, DNA from AD cases &amp;amp; controls, Data analysis, directs study design &amp;amp; joint papers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Clinical collection supply agreement to investigate the genetics of Alzheimer's disease</gtr:description><gtr:id>095D7247-99BA-4369-B0F9-682CB5DDCFE4</gtr:id><gtr:impact>17998437 19013250</gtr:impact><gtr:partnerContribution>GSK funded the collection and storage of DNA samples and clinical and neuroimaging measures on 200 Alzheimer's disease cases in the early stages of disease.</gtr:partnerContribution><gtr:piContribution>We collected 200 AD cases with full clinical work up including volumetric neuroimaging and DNA sampling.</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cardiff University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cardiff University School of Medicine</gtr:department><gtr:description>Population Genetics Techologies (PGT)</gtr:description><gtr:id>A31A4A93-1FDF-449F-BD02-4701ABD483A4</gtr:id><gtr:impact>unknown</gtr:impact><gtr:partnerContribution>Next generation sequencing service, bioinformatic study design, data analysis</gtr:partnerContribution><gtr:piContribution>DNA, AD expertise, data analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Population Genetics Technologies Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Population Genetics Techologies (PGT)</gtr:description><gtr:id>8414A0E0-211D-4C1E-9B5B-0F19F38C153E</gtr:id><gtr:impact>unknown</gtr:impact><gtr:partnerContribution>Next generation sequencing service, bioinformatic study design, data analysis</gtr:partnerContribution><gtr:piContribution>DNA, AD expertise, data analysis</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Swansea University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>CFAS</gtr:description><gtr:id>46B5F731-7996-4AB9-A714-D7A414E6D840</gtr:id><gtr:impact>CFAS prepared for Genetic analysis</gtr:impact><gtr:partnerContribution>Provided cohort</gtr:partnerContribution><gtr:piContribution>We are working together with CFAS to prepare the 3,000 participant cohort for genetic research.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ludwig Maximilian University of Munich (LMU Munich)</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Department of Neurology</gtr:department><gtr:description>GERAD (Genetic and Environmental Risk in Alzheimer's Disease)</gtr:description><gtr:id>8EE7F4F1-5064-41E4-A75D-C56D33C49637</gtr:id><gtr:impact>Publications: PMED IDs: 19734902; 20862329; 20460622, 21085570, 22005930, 22027014, 21220680, 21460840, 20029910, 22445811, 22693153, 21812096, 22442439, 22430674, 22405046, 23150934</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, GWAS data from AD cases and/or controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leadership, management, DNA from AD cases &amp;amp; controls, Data analysis, directs study design &amp;amp; joint papers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Institute of Public Health Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cognitive Function and Ageing Study (CFAS)</gtr:department><gtr:description>Caerphilly Cohort</gtr:description><gtr:id>5DD5DAA7-D8FF-464C-B009-DFE926592B97</gtr:id><gtr:impact>unknown</gtr:impact><gtr:partnerContribution>DNA, Epidemiological data, data analysis, study design</gtr:partnerContribution><gtr:piContribution>AD expertise, Genotyping, Data analysis, study design</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>UCL Institute of Neurology</gtr:department><gtr:description>GERAD (Genetic and Environmental Risk in Alzheimer's Disease)</gtr:description><gtr:id>73AABFBE-A623-4FCB-994C-BFFA3857A37B</gtr:id><gtr:impact>Publications: PMED IDs: 19734902; 20862329; 20460622, 21085570, 22005930, 22027014, 21220680, 21460840, 20029910, 22445811, 22693153, 21812096, 22442439, 22430674, 22405046, 23150934</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, GWAS data from AD cases and/or controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leadership, management, DNA from AD cases &amp;amp; controls, Data analysis, directs study design &amp;amp; joint papers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen's University of Belfast</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Aging group</gtr:department><gtr:description>GERAD Exome Chip Consortium</gtr:description><gtr:id>3B0D5B51-46A8-4409-804D-50DB5B5C6B3E</gtr:id><gtr:impact>Exome chip paper replication on just under 90k subjects is in preparation (submitted to Nature Genetics Letters).</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, access to exome chip data from population controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leads the (GERAD) consortium, management, DNA from AD cases and controls, access to exome chip data from elderly, screened controls, data ananlysis, directs study design</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>GERAD (Genetic and Environmental Risk in Alzheimer's Disease)</gtr:description><gtr:id>7CDA628D-9E0C-4F32-8063-C856C540DFDB</gtr:id><gtr:impact>Publications: PMED IDs: 19734902; 20862329; 20460622, 21085570, 22005930, 22027014, 21220680, 21460840, 20029910, 22445811, 22693153, 21812096, 22442439, 22430674, 22405046, 23150934</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, GWAS data from AD cases and/or controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leadership, management, DNA from AD cases &amp;amp; controls, Data analysis, directs study design &amp;amp; joint papers</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen's University of Belfast</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Aging group</gtr:department><gtr:description>GERAD (Genetic and Environmental Risk in Alzheimer's Disease)</gtr:description><gtr:id>6C97CC33-DA38-4E71-9E89-0045923A71E2</gtr:id><gtr:impact>Publications: PMED IDs: 19734902; 20862329; 20460622, 21085570, 22005930, 22027014, 21220680, 21460840, 20029910, 22445811, 22693153, 21812096, 22442439, 22430674, 22405046, 23150934</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, GWAS data from AD cases and/or controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leadership, management, DNA from AD cases &amp;amp; controls, Data analysis, directs study design &amp;amp; joint papers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Genomics England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Genomics England</gtr:description><gtr:id>AE3124DA-BDC9-4544-807D-223621DFC53F</gtr:id><gtr:impact>None yet</gtr:impact><gtr:partnerContribution>Genomics England have the equipment and infrastructure set up for the very expensive and technical whole exome sequencing.</gtr:partnerContribution><gtr:piContribution>We are in the very early stages of discussion with Genomics England, but we hope to be able to use their facilities for whole Genome sequencing. This will mean that we generate valuable data on the largest EOAD cohort world-wide.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Faculty of Medicine</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Clinical and Experimental Sciences</gtr:department><gtr:description>GERAD (Genetic and Environmental Risk in Alzheimer's Disease)</gtr:description><gtr:id>A4A98D04-A836-4884-9BC9-B7D49E063F3C</gtr:id><gtr:impact>Publications: PMED IDs: 19734902; 20862329; 20460622, 21085570, 22005930, 22027014, 21220680, 21460840, 20029910, 22445811, 22693153, 21812096, 22442439, 22430674, 22405046, 23150934</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, GWAS data from AD cases and/or controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leadership, management, DNA from AD cases &amp;amp; controls, Data analysis, directs study design &amp;amp; joint papers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>School of Clinical Sciences Bristol</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Dementia Research Group</gtr:department><gtr:description>Brains for Dementia Research</gtr:description><gtr:id>8BB69068-1558-4D0F-9342-3020A6571D4E</gtr:id><gtr:impact>BDR aims to set a gold standard for brain donation by coordinating brain banks across the country and providing high quality tissue to researchers.

We hope to enable more people to get involved in brain donation, thus boosting the number of brains available for this important research.

BDR is unique because every brain donor is monitored throughout their later life. This means that a complete medical history is available to accompany their donated brain tissue. This is crucial to allow researchers to make the most of donated tissue.

BDR run an online database of brain tissue. Researchers can search the database and apply to BDR for samples.</gtr:impact><gtr:partnerContribution>Overall Management of BDR Centre, recruitment and Brain Banking</gtr:partnerContribution><gtr:piContribution>Overall Management of BDR Centre, recruitment and Brain Banking</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London (KCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Psychiatry (IoP)</gtr:department><gtr:description>MRC AD Cohort</gtr:description><gtr:id>94117914-965F-491E-915C-8CAEA5AC3218</gtr:id><gtr:impact>16970641 17322133 17530621 17440948 17440933 17373700 17999207 18163421</gtr:impact><gtr:partnerContribution>The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.
The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.
The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.</gtr:partnerContribution><gtr:piContribution>We contributed DNA, clinical follow up information, genotyping and other laboratory work and complex data analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Research Institute for Neurodegerative Diseases (DZNE)</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>GERAD (Genetic and Environmental Risk in Alzheimer's Disease)</gtr:description><gtr:id>E2C6ECAE-462F-470C-AD33-A5958781BCE4</gtr:id><gtr:impact>Publications: PMED IDs: 19734902; 20862329; 20460622, 21085570, 22005930, 22027014, 21220680, 21460840, 20029910, 22445811, 22693153, 21812096, 22442439, 22430674, 22405046, 23150934</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, GWAS data from AD cases and/or controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leadership, management, DNA from AD cases &amp;amp; controls, Data analysis, directs study design &amp;amp; joint papers</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ruprecht Karl University of Heidelberg (Ruprecht-Karls-Universit?t Heidelberg)</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Central Institute of Mental Health Mannheim</gtr:department><gtr:description>GERAD (Genetic and Environmental Risk in Alzheimer's Disease)</gtr:description><gtr:id>4EFEE4AD-576B-4A16-9AC0-7C3DED9E75EB</gtr:id><gtr:impact>Publications: PMED IDs: 19734902; 20862329; 20460622, 21085570, 22005930, 22027014, 21220680, 21460840, 20029910, 22445811, 22693153, 21812096, 22442439, 22430674, 22405046, 23150934</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, GWAS data from AD cases and/or controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leadership, management, DNA from AD cases &amp;amp; controls, Data analysis, directs study design &amp;amp; joint papers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Quest Diagnostics</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Celera Diagnostics</gtr:department><gtr:description>Finding genes for late onset Alzheimer's disease: Collaboration between Washington University, NIMH, Cardiff University and Celera Diagnostics</gtr:description><gtr:id>7086E5F7-AE86-4B33-BB0A-0C285AF0C73D</gtr:id><gtr:impact>17949987 17492769 17725986 18063669 16161859 16385451 16278862 16847012 17317784</gtr:impact><gtr:partnerContribution>Our collaborative group including Celera Diagnostics, Allison Goate and John Hardys research groups undertook a genomewide association study of Alzheimer's disease using genetic pooling and also tested associations with candidate genes. Celera Diagnostics through a sub-contract with MERCK paid for the genomewide association genotyping. Our group took the lead on some studies and contributed samples and intellectual input on others but at all stages all decisions about research design etc were undertaken jointly in a full collaborative fashion. This built on a previous collaboration between ourselves and Allison Goates group from Washington University which spanned over a decade.</gtr:partnerContribution><gtr:piContribution>We undertook a genomewide association study of Alzheimer's disease using genetic pooling and also tested associations with candidate genes. The Celera Diagnostics through a sub-contract with MERCK paid for the genomewide association genotyping. Our group took the lead on some studies and contributed samples and intellectual input on others but at all stages all decisions about research design etc were undertaken jointly in a full collaborative fashion. This built on a previous collaboration between ourselves and Allison Goates group from Washington University which spanned over a decade.</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>JPND Research</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>JPND PERADES</gtr:description><gtr:id>75D6F81A-0409-496E-B352-687FCF4CE403</gtr:id><gtr:impact>The JPND project brings together researchers across Europe to perform vast replication studies of variants of interest in Alzheimer's disease. The project is also the first to begin exome sequencing of the EOAD cohort, which we hope will shed light on the early stages of disease. Importantly, this project brings together the areas of genetics, a variety of omics, polygenic scores, and population studies in a powerful combination to further our knowledge of Alzheimer's disease.</gtr:impact><gtr:partnerContribution>Containing researchers from 11 countries. Exploiting new statistical approaches to genetic data, researchers will calculate polygenic risk scores and use these to identify individuals at both high and low risk of developing Alzheimer's disease.</gtr:partnerContribution><gtr:piContribution>Coordinator of the EU Joint Programme - Neurodegenerative Disease Research PERADES project</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bristol</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Avon Longitudinal Study of Parents and Children (ALSPAC)</gtr:department><gtr:description>Caerphilly Cohort</gtr:description><gtr:id>72E4EBF2-2981-40DC-90F4-542A37C4EED5</gtr:id><gtr:impact>unknown</gtr:impact><gtr:partnerContribution>DNA, Epidemiological data, data analysis, study design</gtr:partnerContribution><gtr:piContribution>AD expertise, Genotyping, Data analysis, study design</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Boston University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>International Genomics of Alzheimer's Project (IGAP)</gtr:description><gtr:id>A0AC2874-A733-4157-B5FC-94CA0E176DD9</gtr:id><gtr:impact>papers in progress</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, GWAS data from AD cases and/or controls, input into study design, input into manuscript preparation, data analysis</gtr:partnerContribution><gtr:piContribution>Co-leadership, management, DNA from AD cases and controls, GWAS data from AD cases and controls, data analysis and joint papers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Neuroscience; IOP</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>GERAD Exome Chip Consortium</gtr:description><gtr:id>08F23111-59C5-4706-AA4D-ECCC3D9EE59C</gtr:id><gtr:impact>Exome chip paper replication on just under 90k subjects is in preparation (submitted to Nature Genetics Letters).</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, access to exome chip data from population controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leads the (GERAD) consortium, management, DNA from AD cases and controls, access to exome chip data from elderly, screened controls, data ananlysis, directs study design</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institutes of Health (NIH)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>GERAD (Genetic and Environmental Risk in Alzheimer's Disease)</gtr:description><gtr:id>6DA3FCF5-60F7-405C-9AFE-34897B8D09FF</gtr:id><gtr:impact>Publications: PMED IDs: 19734902; 20862329; 20460622, 21085570, 22005930, 22027014, 21220680, 21460840, 20029910, 22445811, 22693153, 21812096, 22442439, 22430674, 22405046, 23150934</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, GWAS data from AD cases and/or controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leadership, management, DNA from AD cases &amp;amp; controls, Data analysis, directs study design &amp;amp; joint papers</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Brigham Young University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>GERAD (Genetic and Environmental Risk in Alzheimer's Disease)</gtr:description><gtr:id>843BA41C-3BEC-480B-890C-9A20CA3D539E</gtr:id><gtr:impact>Publications: PMED IDs: 19734902; 20862329; 20460622, 21085570, 22005930, 22027014, 21220680, 21460840, 20029910, 22445811, 22693153, 21812096, 22442439, 22430674, 22405046, 23150934</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, GWAS data from AD cases and/or controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leadership, management, DNA from AD cases &amp;amp; controls, Data analysis, directs study design &amp;amp; joint papers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Jackson Laboratories</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Jackson labs collaboration</gtr:description><gtr:id>C2CC38AF-960A-4BD9-992E-453378FC5DF3</gtr:id><gtr:impact>Attempts so far to tie down both a project plan and committed funding, have not been successful. We are currently exploring alternative methods to whole animal experiments. We hope that in the future we will be able to regenerate interest in this promising collaboration.</gtr:impact><gtr:partnerContribution>Jackson labs provide their expertise in translation of human study findings into small animal transgenic models of genetic diseases.</gtr:partnerContribution><gtr:piContribution>We provide the most up to date genetic human Alzheimer's disease study results and interpretation.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>GlaxoSmithKline Cardiff Collaboration</gtr:description><gtr:id>9A86E16B-91E1-4A28-8CC0-FBD2A628BE88</gtr:id><gtr:impact>This collaboration has been brought under a confidentiality agreement.
Parties involved are experts in genetics and functional biology.</gtr:impact><gtr:partnerContribution>GSK will contribute their expertise in disease models and drug mechanisms.</gtr:partnerContribution><gtr:piContribution>Prof Williams made contact with a GSK rep at the Global Genetics Congress in Baltimore, September 2016.
GSK were extremely interested in collaborating with the Cardiff team. Specifically, GSK have an interest in the latest confidential experimental results and translating these from genetic to biological meaning. This will speed up the Cardiff Team's discovery of potential molecular targets for personalised disease treatment.
Cardiff will contribute expertise in Alzheimer's disease genetics.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>GERAD Exome Chip Consortium</gtr:description><gtr:id>156BC390-056C-41CD-BEA0-19B01DCB7F7F</gtr:id><gtr:impact>Exome chip paper replication on just under 90k subjects is in preparation (submitted to Nature Genetics Letters).</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, access to exome chip data from population controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leads the (GERAD) consortium, management, DNA from AD cases and controls, access to exome chip data from elderly, screened controls, data ananlysis, directs study design</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Hamburg</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>GERAD (Genetic and Environmental Risk in Alzheimer's Disease)</gtr:description><gtr:id>B6DD993F-EC0A-4139-AC76-5FE6B999EEE5</gtr:id><gtr:impact>Publications: PMED IDs: 19734902; 20862329; 20460622, 21085570, 22005930, 22027014, 21220680, 21460840, 20029910, 22445811, 22693153, 21812096, 22442439, 22430674, 22405046, 23150934</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, GWAS data from AD cases and/or controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leadership, management, DNA from AD cases &amp;amp; controls, Data analysis, directs study design &amp;amp; joint papers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Saarland University</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>GERAD Exome Chip Consortium</gtr:description><gtr:id>78B94307-B6E3-4D64-B2C4-727A260DB197</gtr:id><gtr:impact>Exome chip paper replication on just under 90k subjects is in preparation (submitted to Nature Genetics Letters).</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, access to exome chip data from population controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leads the (GERAD) consortium, management, DNA from AD cases and controls, access to exome chip data from elderly, screened controls, data ananlysis, directs study design</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Washington</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>GERAD Exome Chip Consortium</gtr:description><gtr:id>DEC329F5-98E8-4F9B-ACC5-878C1A9613CC</gtr:id><gtr:impact>Exome chip paper replication on just under 90k subjects is in preparation (submitted to Nature Genetics Letters).</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, access to exome chip data from population controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leads the (GERAD) consortium, management, DNA from AD cases and controls, access to exome chip data from elderly, screened controls, data ananlysis, directs study design</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cardiff University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cardiff University School of Medicine</gtr:department><gtr:description>Caerphilly Cohort</gtr:description><gtr:id>15244264-82D9-4496-AD4E-7312C55D9BA8</gtr:id><gtr:impact>unknown</gtr:impact><gtr:partnerContribution>DNA, Epidemiological data, data analysis, study design</gtr:partnerContribution><gtr:piContribution>AD expertise, Genotyping, Data analysis, study design</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Fondazione Santa Lucia</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>GERAD Exome Chip Consortium</gtr:description><gtr:id>9CC37FDA-DB71-4B18-8B0A-33A754DEB63B</gtr:id><gtr:impact>Exome chip paper replication on just under 90k subjects is in preparation (submitted to Nature Genetics Letters).</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, access to exome chip data from population controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leads the (GERAD) consortium, management, DNA from AD cases and controls, access to exome chip data from elderly, screened controls, data ananlysis, directs study design</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Autonomous University of Madrid (Universidad Aut?noma de Madrid UAM)</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:description>GERAD Exome Chip Consortium</gtr:description><gtr:id>18F8BEF1-D522-4E73-A4AE-5D6C46C38B14</gtr:id><gtr:impact>Exome chip paper replication on just under 90k subjects is in preparation (submitted to Nature Genetics Letters).</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, access to exome chip data from population controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leads the (GERAD) consortium, management, DNA from AD cases and controls, access to exome chip data from elderly, screened controls, data ananlysis, directs study design</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ludwig Maximilian University of Munich (LMU Munich)</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>GERAD Exome Chip Consortium</gtr:description><gtr:id>12512FA3-0DF6-4C16-AA2F-ED14F3181FD9</gtr:id><gtr:impact>Exome chip paper replication on just under 90k subjects is in preparation (submitted to Nature Genetics Letters).</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, access to exome chip data from population controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leads the (GERAD) consortium, management, DNA from AD cases and controls, access to exome chip data from elderly, screened controls, data ananlysis, directs study design</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Hospital de Sant Pau</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:description>GERAD Exome Chip Consortium</gtr:description><gtr:id>D0B576D2-B90F-4784-9799-DA4BFA0495B0</gtr:id><gtr:impact>Exome chip paper replication on just under 90k subjects is in preparation (submitted to Nature Genetics Letters).</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, access to exome chip data from population controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leads the (GERAD) consortium, management, DNA from AD cases and controls, access to exome chip data from elderly, screened controls, data ananlysis, directs study design</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Arizona Association for Play Therapy (AZAPT)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>AZAPT</gtr:description><gtr:id>937CC6BB-4790-4A4F-A2E3-A882AAA85311</gtr:id><gtr:impact>none yet</gtr:impact><gtr:partnerContribution>MOLECULAR BIOLOGY, data analysis, cell culture</gtr:partnerContribution><gtr:piContribution>MOLECULAR BIOLOGY, data analysis, cell culture</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bonn</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Department of Psychiatry</gtr:department><gtr:description>GERAD Exome Chip Consortium</gtr:description><gtr:id>6A237519-433C-4766-9847-F5DD5EB8C544</gtr:id><gtr:impact>Exome chip paper replication on just under 90k subjects is in preparation (submitted to Nature Genetics Letters).</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, access to exome chip data from population controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leads the (GERAD) consortium, management, DNA from AD cases and controls, access to exome chip data from elderly, screened controls, data ananlysis, directs study design</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Dublin</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:department>Trinity College Dublin</gtr:department><gtr:description>MRC AD Cohort</gtr:description><gtr:id>2FB0F3BE-EBF7-4F5D-9CD5-1CF7330EAF16</gtr:id><gtr:impact>16970641 17322133 17530621 17440948 17440933 17373700 17999207 18163421</gtr:impact><gtr:partnerContribution>The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.
The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.
The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.</gtr:partnerContribution><gtr:piContribution>We contributed DNA, clinical follow up information, genotyping and other laboratory work and complex data analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>School of Clinical Sciences Bristol</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Dementia Research Group</gtr:department><gtr:description>GERAD (Genetic and Environmental Risk in Alzheimer's Disease)</gtr:description><gtr:id>595FA887-5D5B-4CA1-BA16-06EB9C6FA649</gtr:id><gtr:impact>Publications: PMED IDs: 19734902; 20862329; 20460622, 21085570, 22005930, 22027014, 21220680, 21460840, 20029910, 22445811, 22693153, 21812096, 22442439, 22430674, 22405046, 23150934</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, GWAS data from AD cases and/or controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leadership, management, DNA from AD cases &amp;amp; controls, Data analysis, directs study design &amp;amp; joint papers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>School of Biology Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Genetics and Genomics</gtr:department><gtr:description>GERAD (Genetic and Environmental Risk in Alzheimer's Disease)</gtr:description><gtr:id>53349840-61D9-4CDC-A358-18F70C787725</gtr:id><gtr:impact>Publications: PMED IDs: 19734902; 20862329; 20460622, 21085570, 22005930, 22027014, 21220680, 21460840, 20029910, 22445811, 22693153, 21812096, 22442439, 22430674, 22405046, 23150934</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, GWAS data from AD cases and/or controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leadership, management, DNA from AD cases &amp;amp; controls, Data analysis, directs study design &amp;amp; joint papers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Navarra</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:description>GERAD Exome Chip Consortium</gtr:description><gtr:id>DE0DF132-3AE0-46EA-BACA-0B8352FFF989</gtr:id><gtr:impact>Exome chip paper replication on just under 90k subjects is in preparation (submitted to Nature Genetics Letters).</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, access to exome chip data from population controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leads the (GERAD) consortium, management, DNA from AD cases and controls, access to exome chip data from elderly, screened controls, data ananlysis, directs study design</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London (KCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Psychiatry (IoP)</gtr:department><gtr:description>GERAD (Genetic and Environmental Risk in Alzheimer's Disease)</gtr:description><gtr:id>5AD541E1-D05A-4B9F-B525-BACABFF7FD51</gtr:id><gtr:impact>Publications: PMED IDs: 19734902; 20862329; 20460622, 21085570, 22005930, 22027014, 21220680, 21460840, 20029910, 22445811, 22693153, 21812096, 22442439, 22430674, 22405046, 23150934</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, GWAS data from AD cases and/or controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leadership, management, DNA from AD cases &amp;amp; controls, Data analysis, directs study design &amp;amp; joint papers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Faculty of Medical and Human Sciences</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Neuroscience Research Institute (NRI)</gtr:department><gtr:description>GERAD (Genetic and Environmental Risk in Alzheimer's Disease)</gtr:description><gtr:id>CABF9700-58CF-4E4F-B6A1-FDC415C6CB75</gtr:id><gtr:impact>Publications: PMED IDs: 19734902; 20862329; 20460622, 21085570, 22005930, 22027014, 21220680, 21460840, 20029910, 22445811, 22693153, 21812096, 22442439, 22430674, 22405046, 23150934</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, GWAS data from AD cases and/or controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leadership, management, DNA from AD cases &amp;amp; controls, Data analysis, directs study design &amp;amp; joint papers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Neurology</gtr:department><gtr:description>UK biobank neurodenerative disease platform</gtr:description><gtr:id>A8854B30-D513-49BA-9679-D4D0EA2376E8</gtr:id><gtr:impact>Grant application currently under review</gtr:impact><gtr:partnerContribution>co-investigators on grant application</gtr:partnerContribution><gtr:piContribution>Named investigator on grant application</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cardiff University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cardiff University School of Medicine</gtr:department><gtr:description>GERAD Exome Chip Consortium</gtr:description><gtr:id>61977808-6275-4EB1-9989-8F2D06584230</gtr:id><gtr:impact>Exome chip paper replication on just under 90k subjects is in preparation (submitted to Nature Genetics Letters).</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, access to exome chip data from population controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leads the (GERAD) consortium, management, DNA from AD cases and controls, access to exome chip data from elderly, screened controls, data ananlysis, directs study design</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Freiburg</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>GERAD (Genetic and Environmental Risk in Alzheimer's Disease)</gtr:description><gtr:id>4C750CB0-9A2A-4CA4-8B85-91ED5993DC38</gtr:id><gtr:impact>Publications: PMED IDs: 19734902; 20862329; 20460622, 21085570, 22005930, 22027014, 21220680, 21460840, 20029910, 22445811, 22693153, 21812096, 22442439, 22430674, 22405046, 23150934</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, GWAS data from AD cases and/or controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leadership, management, DNA from AD cases &amp;amp; controls, Data analysis, directs study design &amp;amp; joint papers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute for Ageing and Health</gtr:department><gtr:description>Brains for Dementia Research</gtr:description><gtr:id>45B2B609-6FEF-45DC-844A-189AE1598DF9</gtr:id><gtr:impact>BDR aims to set a gold standard for brain donation by coordinating brain banks across the country and providing high quality tissue to researchers.

We hope to enable more people to get involved in brain donation, thus boosting the number of brains available for this important research.

BDR is unique because every brain donor is monitored throughout their later life. This means that a complete medical history is available to accompany their donated brain tissue. This is crucial to allow researchers to make the most of donated tissue.

BDR run an online database of brain tissue. Researchers can search the database and apply to BDR for samples.</gtr:impact><gtr:partnerContribution>Overall Management of BDR Centre, recruitment and Brain Banking</gtr:partnerContribution><gtr:piContribution>Overall Management of BDR Centre, recruitment and Brain Banking</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Severnside Alliance for Translational Research (SARTRE)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Translating the effects of new susceptibility genes for AD into disease mechanisms and potential drug screening</gtr:description><gtr:id>545CFB2E-2DD0-42E9-942E-2473D163A3E1</gtr:id><gtr:impact>unknown</gtr:impact><gtr:partnerContribution>Functional expertise, study design, co-supervision of research fellow Amy Gerrish</gtr:partnerContribution><gtr:piContribution>AD expertise, genotying, data analysis, study design, co-supervision of research fellow Amy Gerrish</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Eisai Ltd</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:description>Eisai Collaboration</gtr:description><gtr:id>313C2650-2A16-4067-87D8-2946A6DEC0B1</gtr:id><gtr:impact>None yet</gtr:impact><gtr:partnerContribution>Expertise in functional biology</gtr:partnerContribution><gtr:piContribution>We are identifying important genes and pathways involved in Alzheimer's disease for further investigation in functional experiments and drug-based tests.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Brigham Young University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>GERAD Exome Chip Consortium</gtr:description><gtr:id>3F0DB0E6-6270-4C89-98D2-C6A1FCF25B23</gtr:id><gtr:impact>Exome chip paper replication on just under 90k subjects is in preparation (submitted to Nature Genetics Letters).</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, access to exome chip data from population controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leads the (GERAD) consortium, management, DNA from AD cases and controls, access to exome chip data from elderly, screened controls, data ananlysis, directs study design</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>NIHR Oxford Biomedical Research Centre</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Oxford Project to Investigate Memory and Ageing (OPTIMA)</gtr:department><gtr:description>GERAD (Genetic and Environmental Risk in Alzheimer's Disease)</gtr:description><gtr:id>0DF7983E-D95E-4821-A170-F6D2F400073B</gtr:id><gtr:impact>Publications: PMED IDs: 19734902; 20862329; 20460622, 21085570, 22005930, 22027014, 21220680, 21460840, 20029910, 22445811, 22693153, 21812096, 22442439, 22430674, 22405046, 23150934</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, GWAS data from AD cases and/or controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leadership, management, DNA from AD cases &amp;amp; controls, Data analysis, directs study design &amp;amp; joint papers</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Free University of Berlin</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>GERAD (Genetic and Environmental Risk in Alzheimer's Disease)</gtr:description><gtr:id>E042377B-FB3C-42CF-8CD1-6E2402B62AA0</gtr:id><gtr:impact>Publications: PMED IDs: 19734902; 20862329; 20460622, 21085570, 22005930, 22027014, 21220680, 21460840, 20029910, 22445811, 22693153, 21812096, 22442439, 22430674, 22405046, 23150934</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, GWAS data from AD cases and/or controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leadership, management, DNA from AD cases &amp;amp; controls, Data analysis, directs study design &amp;amp; joint papers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Zurich (Universit?t Z?rich UZH)</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:department>Functional Genomics Centre Zurich (FGCZ)</gtr:department><gtr:description>GERAD (Genetic and Environmental Risk in Alzheimer's Disease)</gtr:description><gtr:id>CD85C072-B110-43C6-8471-43F4A6F60308</gtr:id><gtr:impact>Publications: PMED IDs: 19734902; 20862329; 20460622, 21085570, 22005930, 22027014, 21220680, 21460840, 20029910, 22445811, 22693153, 21812096, 22442439, 22430674, 22405046, 23150934</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, GWAS data from AD cases and/or controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leadership, management, DNA from AD cases &amp;amp; controls, Data analysis, directs study design &amp;amp; joint papers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cardiff University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Neuropsychiatric Genetics and Genomics</gtr:department><gtr:description>GERAD (Genetic and Environmental Risk in Alzheimer's Disease)</gtr:description><gtr:id>E9C817AC-5759-4179-8512-1CF93BF96F4D</gtr:id><gtr:impact>Publications: PMED IDs: 19734902; 20862329; 20460622, 21085570, 22005930, 22027014, 21220680, 21460840, 20029910, 22445811, 22693153, 21812096, 22442439, 22430674, 22405046, 23150934</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, GWAS data from AD cases and/or controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leadership, management, DNA from AD cases &amp;amp; controls, Data analysis, directs study design &amp;amp; joint papers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>School of Clinical Medicine</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Public Health and Primary Care</gtr:department><gtr:description>MRC AD Cohort</gtr:description><gtr:id>5CCD0780-8C0D-42A0-B9FA-70D6B66ADEB2</gtr:id><gtr:impact>16970641 17322133 17530621 17440948 17440933 17373700 17999207 18163421</gtr:impact><gtr:partnerContribution>The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.
The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.
The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.</gtr:partnerContribution><gtr:piContribution>We contributed DNA, clinical follow up information, genotyping and other laboratory work and complex data analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Genetic and Environmental Risk in Alzheimer's Disease (GERAD)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>International Genomics of Alzheimer's Project (IGAP)</gtr:description><gtr:id>8C9AB80C-176C-4767-BA58-3779F1DB2EC0</gtr:id><gtr:impact>papers in progress</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, GWAS data from AD cases and/or controls, input into study design, input into manuscript preparation, data analysis</gtr:partnerContribution><gtr:piContribution>Co-leadership, management, DNA from AD cases and controls, GWAS data from AD cases and controls, data analysis and joint papers</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Brain, Behaviour and Mental Health</gtr:department><gtr:description>Brains for Dementia Research</gtr:description><gtr:id>8EDE4B71-0778-4F21-A55D-F7AB49ACB059</gtr:id><gtr:impact>BDR aims to set a gold standard for brain donation by coordinating brain banks across the country and providing high quality tissue to researchers.

We hope to enable more people to get involved in brain donation, thus boosting the number of brains available for this important research.

BDR is unique because every brain donor is monitored throughout their later life. This means that a complete medical history is available to accompany their donated brain tissue. This is crucial to allow researchers to make the most of donated tissue.

BDR run an online database of brain tissue. Researchers can search the database and apply to BDR for samples.</gtr:impact><gtr:partnerContribution>Overall Management of BDR Centre, recruitment and Brain Banking</gtr:partnerContribution><gtr:piContribution>Overall Management of BDR Centre, recruitment and Brain Banking</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Goethe University Frankfurt</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>GERAD (Genetic and Environmental Risk in Alzheimer's Disease)</gtr:description><gtr:id>8F9EB830-BE83-4181-8BAB-9521DFDACACF</gtr:id><gtr:impact>Publications: PMED IDs: 19734902; 20862329; 20460622, 21085570, 22005930, 22027014, 21220680, 21460840, 20029910, 22445811, 22693153, 21812096, 22442439, 22430674, 22405046, 23150934</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, GWAS data from AD cases and/or controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leadership, management, DNA from AD cases &amp;amp; controls, Data analysis, directs study design &amp;amp; joint papers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>UCL Institute of Neurology</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Prion Unit</gtr:department><gtr:description>GERAD Exome Chip Consortium</gtr:description><gtr:id>46B30303-C5C7-41A3-A92E-7469EE6EEAE5</gtr:id><gtr:impact>Exome chip paper replication on just under 90k subjects is in preparation (submitted to Nature Genetics Letters).</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, access to exome chip data from population controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leads the (GERAD) consortium, management, DNA from AD cases and controls, access to exome chip data from elderly, screened controls, data ananlysis, directs study design</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oviedo</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:description>GERAD Exome Chip Consortium</gtr:description><gtr:id>9B81CF6B-E53C-4557-9D71-D344416C513E</gtr:id><gtr:impact>Exome chip paper replication on just under 90k subjects is in preparation (submitted to Nature Genetics Letters).</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, access to exome chip data from population controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leads the (GERAD) consortium, management, DNA from AD cases and controls, access to exome chip data from elderly, screened controls, data ananlysis, directs study design</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Pennsylvania School of Medicine</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Alzheimer's Disease Genetics Consortium (ADGC)</gtr:department><gtr:description>International Genomics of Alzheimer's Project (IGAP)</gtr:description><gtr:id>12B9B7B7-928E-40B0-9536-AB1E90C61305</gtr:id><gtr:impact>papers in progress</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, GWAS data from AD cases and/or controls, input into study design, input into manuscript preparation, data analysis</gtr:partnerContribution><gtr:piContribution>Co-leadership, management, DNA from AD cases and controls, GWAS data from AD cases and controls, data analysis and joint papers</gtr:piContribution><gtr:sector>Learned Society</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London (KCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>NIHR Biomedical Research Centre</gtr:department><gtr:description>UK biobank neurodenerative disease platform</gtr:description><gtr:id>0A8A9F8C-DBE6-47FF-A323-5768A8CDA2D4</gtr:id><gtr:impact>Grant application currently under review</gtr:impact><gtr:partnerContribution>co-investigators on grant application</gtr:partnerContribution><gtr:piContribution>Named investigator on grant application</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Eli Lilly &amp; Company Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Eli Lilly Collaboration</gtr:description><gtr:id>9FFFA8AA-5DEC-4308-BBC8-A13A04BC7FD2</gtr:id><gtr:impact>unknown</gtr:impact><gtr:partnerContribution>scientific input, co-direct study design, funding</gtr:partnerContribution><gtr:piContribution>Access to patient bio-samples, co-directs study design</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Mayo Foundation for Medical Education and Research (MFMER)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>GERAD (Genetic and Environmental Risk in Alzheimer's Disease)</gtr:description><gtr:id>48ECFA15-9A03-4CB4-9C54-A2A2445491B3</gtr:id><gtr:impact>Publications: PMED IDs: 19734902; 20862329; 20460622, 21085570, 22005930, 22027014, 21220680, 21460840, 20029910, 22445811, 22693153, 21812096, 22442439, 22430674, 22405046, 23150934</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, GWAS data from AD cases and/or controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leadership, management, DNA from AD cases &amp;amp; controls, Data analysis, directs study design &amp;amp; joint papers</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Washington University at St Louis</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>GERAD (Genetic and Environmental Risk in Alzheimer's Disease)</gtr:description><gtr:id>F64A110D-F5F7-4C8E-A416-0D4202547023</gtr:id><gtr:impact>Publications: PMED IDs: 19734902; 20862329; 20460622, 21085570, 22005930, 22027014, 21220680, 21460840, 20029910, 22445811, 22693153, 21812096, 22442439, 22430674, 22405046, 23150934</gtr:impact><gtr:partnerContribution>DNA from AD cases and/or controls, GWAS data from AD cases and/or controls, input into study design, input into manuscript preparation</gtr:partnerContribution><gtr:piContribution>Leadership, management, DNA from AD cases &amp;amp; controls, Data analysis, directs study design &amp;amp; joint papers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Funding for medical research is dangerously low</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8471726B-7819-46C0-A4A6-DEC38A17B37A</gtr:id><gtr:impact>Professor Julie Williams, School of Medicine, says funding for medical research is dangerously low. (Daily Telegraph 9.2.11 http://www.medicalnewstoday.com/articles/216363.php )


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC CNGG/NCMH/CADR stand at the Wales Gene park's Genetics and Genomics Conference</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8DC30D15-11EF-4601-B2CA-7DDECA0EA842</gtr:id><gtr:impact>Representatives from the Alzheimer's Genetics Team manned a stand at the Wales Gene Park's Genetics and Genomics Conference on 22nd June, 2016. A number of individuals were interested in discussing the research environment, and how participants could help with discovery science.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://www.eventbrite.co.uk/e/genetics-and-genomics-for-the-3rd-generation-tickets-24871582573</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>House of Lords Lunch</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>113A376B-0BC5-4C9F-8B1D-226D49D16102</gtr:id><gtr:impact>Lunch discussion at The House of Lords

unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>EISA Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>71EA8AB8-FACA-42BC-A76F-0655E1F710B4</gtr:id><gtr:impact>Delivered talk entitled - Dementia and Cognitive Dysfunction

Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>5 new Alzheimer's genes</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>283A270F-AC8B-40A1-AC73-5203A2975F6C</gtr:id><gtr:impact>A leading University scientist's search for factors that increase the risk of developing Alzheimer's has uncovered five new genes to help pinpoint what's going wrong in the brain. Professor Julie Williams from the University's MRC Centre for Neuropsychiatric Genetics and Genomics, School of Medicine, has identified an additional five new genes - bringing the total number of genes that increase the risk of developing Alzheimer's to ten. (BBC Radio 4, Today programme, BBC Radio Wales, Good Morning Wales, BBC Wales Breakfast News, ITV Wales Breakfast News; BBC On-line, 4.4.2011, www.bbc.co.uk/news/health-12937131; The Mirror, 4.4.11, www.mirror.co.uk/news/top-stories/2011/04/04/genetic-study-uncovers-causes-of-alzheimer-s-disease-115875-23036111/; The Independent, 4.4.11, http://www.independent.co.uk/news/science/a-test-for-alzheimers-disease-ndash-but-will-anyone-want-to-take-it-2261426.html; The Telegraph, 4.4.11, www.telegraph.co.uk/health/healthnews/8422477/New-genes-found-in-hunt-for-Alzheimers-disease-cure.html; Daily Mail, 4.4.11, www.dailymail.co.uk/health/article-1373063/The-genetic-clues-help-prevent-Alzheimers-disease.html?ito=feeds-newsxml; 


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Annual ART Conference</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>7911280A-BD9B-43B5-9E6B-6108D4F5D4E9</gtr:id><gtr:impact>Attended and presented at the annual ART conference

not known</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dementia: Making a Difference. Television Programme for BBC2</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>52BC0C4A-B22A-4386-8274-4BB3C4BE2529</gtr:id><gtr:impact>Television programme about the work of Julie Williams http://www.bbc.co.uk/programmes/b01j0qwr

unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Wales Gene Park 10th Anniversary, Cardiff &quot;Defining the genetic architecture of Alzheimer's disease&quot;</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>3433D0CE-B75B-46C8-9E66-AFD34A4ABA1C</gtr:id><gtr:impact>Provided a talk entitled &amp;quot;Defining the Genetic Architecture of Alzheimer's Disease&amp;quot;

Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.walesgenepark.cardiff.ac.uk/wp-content/uploads/2013/04/4_Julie_Williams.pdf</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Welsh language champions in NHS health boards</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>0BA9FC2E-E78B-4C38-9C5B-9CB931B12DF7</gtr:id><gtr:impact>Professor Julie Williams, School of Medicine comments on plans to appoint Welsh language champions in NHS health boards. (Western Mail, 7/6/10, p25)


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seven preventable risk factors which can be attributed to Alzheimer's disease</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>FD41B630-7493-4AC1-92FE-35D3C402AB9D</gtr:id><gtr:impact>Professor Julie Williams, School of Medicine, comments on a new study by scientists in the US which shows seven preventable risk factors which can be attributed to Alzheimer's disease. (Western Mail, 20.07.11, p.10); (South Wales Echo, 20.07.11, p.20)


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Grandround presentation - NHS Cardiff Postgraduate Centre</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>8ACA59E2-B4D8-4818-AD6F-9C1F0BC0A37F</gtr:id><gtr:impact>Defining the genetic architecture for Alzheimer's Disease

unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Update on medical and scientific advances in prevention and treatment of dementia</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7D7D045E-1677-4D4D-9573-8F8CB9BF4D0D</gtr:id><gtr:impact>UK dementia Congress Plenary: Update on medical and scientific advances in previention and treatment of dementia

unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British Neuroscience Conference, Harrogate</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>03DAF803-326A-4283-8430-D50F65056F0E</gtr:id><gtr:impact>Finding genes for developmental dyslexia

unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>International Genomics of Alzheimer's Project</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8D8EE525-B6B0-4A4E-B979-295104DCF6DA</gtr:id><gtr:impact>A group led by Professor Julie Williams, School of Medicine is one of four involved in the International Genomics of Alzheimer's Project - a collaboration formed to discover and map the genes that contribute to Alzheimer's disease. http://www.medicalnewstoday.com/articles/215425.php 


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Defining the genetic architecture of Alzheimer's disease</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>DBBE0E1C-DB73-4FE2-8B16-006CF3B944CE</gtr:id><gtr:impact>German National Genome Research Network (NGFN) Conference - 27th September 2011 - Keynote speaker


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>It is time to make mental health research a funding priority</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>00E924E7-01D9-4478-91A9-9E9B309B974A</gtr:id><gtr:impact>Professor Julie Williams, School of Medicine, argues in an essay that it is time to make mental health research a funding priority. Cardiff University has committed to this in creating the new Neuroscience and Mental Health Research Institute - and Professor Williams calls on other decision makers and funders to do likewise. (W.Mail, 9.8.10 p26) 


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The Academy of Medical Sciences, Cardiff</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>779A7FC5-66AC-4F08-8A20-A18B54CCB8E6</gtr:id><gtr:impact>Successful collaborations with basic scientists


unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Defining the genetic architecture of Alzheimer's disease</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7E8EE9EE-4ECE-4A21-B9C1-86D84E49ACB2</gtr:id><gtr:impact>Alzheimer's Research Trust Research Day - Manchester ART Centre, Chancellors conference centre 27th January 2011 - Keynote speaker


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>GEHC/CU Symposium</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>68BA933F-5463-4AD2-8EC3-B22A0933D954</gtr:id><gtr:impact>Provided a talk entitled &amp;quot;Opportunities in Wales: WG&amp;quot; at the Joint GE Healthcare / Cardiff University Symposium (Theme: Stem Cell technologies)

Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Third sector organisations</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>New Alzheimer's risk genes discovered in record study</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9623FAED-D3ED-4844-BBC7-4E96A8310F4F</gtr:id><gtr:impact>A press release was issued highlighting the discovery of 11 new susceptibility genes for AD by the IGAP consortium.

Details of these findings were published by all of the main UK news organisations.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.cardiff.ac.uk/news/articles/new-alzheimers-risk-genes-discovered-in-record-study-11975.html</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Finding genes for developmental dyslexia</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>DD8B748C-584B-4153-93D5-F853DE6D25E4</gtr:id><gtr:impact>7th International Conference - British Dyslexia Association 2 - 5th June 2011 - Invited speaker


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ITV news interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4424D03D-82F2-4913-8F64-F67C0B11FFCD</gtr:id><gtr:impact>ITV news interview with Julie Williams discussing research and new funding.

Increase in requests for information from individuals wishing to take part in research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.itv.com/news/wales/update/2014-04-03/cardiff-university-leads-new-global-alzheimers-research/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Time Magazine - Medical breakthroughs of 2009</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>16C4CE43-41CD-4C01-B99A-F0E01E6C1BE1</gtr:id><gtr:impact>A key University study which helped uncover two new genes associated with Alzheimer's disease has been recognised as one of the top 10 medical breakthroughs of 2009 by TIME Magazine.

International acknowledgement of research findings.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ITV Wales interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>5108ACA0-7161-4B54-8441-4BC9561564B8</gtr:id><gtr:impact>Interview with James Crichton-Smith at ITV Wales - ITV Wales are running a piece on early onset Alzheimers.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>2 new genetic variations linked with Alzheimer's</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>41E90B2C-64CC-4229-BB39-1279D4F5A780</gtr:id><gtr:impact>An international collaboration of scientists, including expertise from Cardiff University, has uncovered two new genetic variations linked with Alzheimer's, opening up new research avenues into the disease. The two newly discovered genetic variations do not predict a person's risk of developing Alzheimer's, but the authors of the paper, which appears in The Journal of the American Medical Association (JAMA) speak of new valuable insights for scientists working on the disease. Professor Julie Williams, Cardiff University, is a principal investigator of the study, led by Professor Monique Breteler, University Medical Center Rotterdam. The research also builds on the discovery led by Professor Williams last year of the first new genes associated with Alzheimer's in a generation.


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Genetics of Alzheimer's Disease and its translation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>CF4CDD21-5BA6-44B1-8EC2-B93A839948EE</gtr:id><gtr:impact>Neurodem Research Development Group presentation on Genetics of Alzheimer's Disease

unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Alzheimer's Society legacy event</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>929CFC84-2ECE-4E8A-8192-6CE3E185142D</gtr:id><gtr:impact>Dr Rebecca Sims spoke at an Alzheimer's Society legacy event

An increase in legacy donations</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Fiona Phillips visit</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>36B25EE5-9413-4415-B8D0-FF2AE875F63D</gtr:id><gtr:impact>Journalist and broadcaster Fiona Phillips is to visit the University's MRC Centre for Neuropsychiatric Genetics and Genomics this week to investigate leading Alzheimer's research. (South Wales Echo, 21.07.11, p.9)


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Funding for Alzheimer's research</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A5D00AA5-CB61-4289-ABAA-BFC93BD18A6A</gtr:id><gtr:impact>Scientists in Wales researching the causes of dementia are at a &amp;quot;major disadvantage&amp;quot; because the nation does not fund such projects says Professor Julie Williams, School of Medicine. (Western Mail, 4/2/10, p14) Professor Williams is also interviewed about funding for Alzheimer's research. &amp;nbsp;(BBC Wales News, 4/2/10)


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Genetic modifiers workshop</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0C5EE8D7-6CB9-4340-BFD6-5EFDDA8F3F5C</gtr:id><gtr:impact>Progress in neurodegenerative disorders

Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Funding for Alzheimer's research</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>63F110DF-E415-4E77-A169-B15B816B8DA7</gtr:id><gtr:impact>Professor Julie Williams, School of Medicine, is interviewed regarding funding for Alzheimer's research. &amp;nbsp;(BBC Radio Wales, 2.2.10)


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Awarded ?800K to lead new genetic research into Alzheimer's</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A8827536-D5BE-4A19-A2B1-56E7A4F179B3</gtr:id><gtr:impact>Professor Julie Williams, School of Medicine, has been awarded &amp;pound;800K to lead new genetic research into Alzheimer's (Business Weekly, 14.10.10) 


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ICAD, Paris</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B9395D03-F132-495F-A249-7AFCFFC87DE9</gtr:id><gtr:impact>Role of the Immune System and Inflammatory Response in the Aetiology of Alzheimer's Disease

unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>11 new susceptibility genes linked with Alzheimer's disease</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>DB96A3ED-DBC4-4737-B33E-393DDAC8FF1E</gtr:id><gtr:impact>In the largest ever study of its kind, an international collaboration of scientists, jointly led by Cardiff, has uncovered 11 new susceptibility genes linked with Alzheimer's disease. 


Worldwide TV and Newspaper Coverage received</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Further insights into the causes of Alzheimer's disease</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3B042CED-43C8-4C58-A376-CC067030FB3B</gtr:id><gtr:impact>UN Older Persons' Day - 29th Sept 2011 - Invited speaker


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio discussion</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>A8495DD6-0532-4018-9030-1ABC6A32B1CB</gtr:id><gtr:impact>BBC Radio Wales Jason Mohammed show discussing progress in Alzheimer's Disease Research

unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Zeurs Austria - Drugs Genetics</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D345AF63-058F-4BAF-94D3-B6ADAEC98B6B</gtr:id><gtr:impact>Presented talk entitled - Defining the genetic architecture for AD

not known</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>2013 Open Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>D4202D03-2BEB-422F-94DF-3A61265D31B9</gtr:id><gtr:impact>150 people attended an open day which included a series of talks, poster presentations, lab tours and informal question and answer sessions.

The event was featured on the BBC Radio Wales Science Cafe Show which resulted in increased enquiries from members of the public.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:url>http://www.alzheimersresearchuk.org/news-detail/10941/Public-invited-to-day-of-dementia-talks-tours-theatre-and-music/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Finding the causes of Alzheimer's disease</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>C514480F-60A1-4153-A369-ECB1E0D177B4</gtr:id><gtr:impact>Delivered a public lecture as part of the Science in Health Public Lecture Series entitled &amp;quot;Finding the causes of Alzheimer's disease&amp;quot;

Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://medicine.cf.ac.uk/event/finding-the-causes-of-alzheimers-disease/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The Alzheimer's Society first all-Wales conference in Swansea</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>4B5FD701-A6C6-4BAA-A6E3-8DFA001D2C41</gtr:id><gtr:impact>Professor Julie Williams, School of Medicine, was a keynote speaker on the genetic causes of Alzheimer's at the Alzheimer's Society first all-Wales conference in Swansea. (W.Mail 12.7.11 p12)


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Western Mail/ Wales online interview</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>78454C0D-61EA-4348-96D3-5053A1BCC295</gtr:id><gtr:impact>An article was published online and in print

not known</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.walesonline.co.uk/lifestyle/showbiz/how-professor-julie-williams-went-2017479</gtr:url><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ARUK Public Engagement open day</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>D15A65AF-64B8-45C5-B287-BE87D4CE81E8</gtr:id><gtr:impact>Public engagement</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Defining the genetic architecture of Alzheimer's disease</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4DB7F127-7AFD-41A4-9BD2-136318D71FAB</gtr:id><gtr:impact>Royal College of Psychiatrists International Congress 29th June 2011 - Invited speaker


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ART - Westminster</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>82907DEC-4B5D-4ED8-836C-FFC6CEC27CE7</gtr:id><gtr:impact>Dissemination of research findings to parliamentarians

not known</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>U3A Brecon</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0DC7C01B-DB0E-43DE-8E80-AD80C1C99DA1</gtr:id><gtr:impact>Dissemination of Alzheimers research findings

not known</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Defining the genetic architecture of Alzheimer's disease</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>5568116C-D3C1-4C1B-BF29-2E3CCA6FFB06</gtr:id><gtr:impact>Presentation for the Waterloo foundation

unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC Panorama</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>457F4D0D-33A2-4E45-8D13-C10044C2D258</gtr:id><gtr:impact>Prof Julie Williams Research Team were approached to be involved in a BBC documentary. The documentary followed one of our research participants and his family through everyday life with Alzheimer's disease. Field workers and laboratory staff were also filmed in their roles. The documentary was screened on BBC1 in Panorama on 2nd June 2016.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SciScreen Dementia Event</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>7CFF5768-2C9C-431E-87CF-CE15D52536C5</gtr:id><gtr:impact>Dr Rebecca Sims gave a public presentation on Dementia research before a free screening of the film &amp;quot;Away from Her&amp;quot;, post-film discussion and free drinks reception. The purpose of the event is for scientists to engage with the general public for mutual benefit. The presentation was well received, and the discussions were lively.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science Cafe talk 10th May 2016</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>5D7C691C-B794-49A3-B8F7-7FC1F3116A4C</gtr:id><gtr:impact>A talk was given by PhD student and Neurologist, Dr Jude Harrison. Science Cafe events are designed to encourage the general public to engage with science in an informal environment.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Rugby legend's research donation</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>871CD7F9-6A5F-4903-8098-A9BF745D0532</gtr:id><gtr:impact>A Wales and British Lions rugby legend will help boost the University's world-leading Alzheimer's research by chipping-in with a charity donation.

Charitable donation received</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.cardiff.ac.uk/news/articles/rugby-legends-research-donation-9461.html</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ART Event - Bournemouth</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>0943E075-26C7-491F-A59F-B225BC7DC077</gtr:id><gtr:impact>Disseminating research findings to research participants

not know</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Un o Bob Tri (One of Every Three) Television Programme for S4C</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>ED334685-5246-46A0-BC18-DD0BB330CEC2</gtr:id><gtr:impact>Interview for TV programme http://www.s4c.co.uk/ffeithiol/e_un_bob_tri.shtml

unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The International Genomics of Alzheimer's Project (IGAP)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>369FEF39-CD55-406F-AFFD-7B28EA0FD48B</gtr:id><gtr:impact>The International Genomics of Alzheimer's Project (IGAP) - a group of leading experts in Alzheimer's research from Europe, USA and the rest of the world has been established. The new international group includes Professor Julie Williams, School of Medicine (PR Newswire, 01.02.11, www.prnewswire.com/news-releases/first-international-collaboration-on-the-genetics-of-alzheimers-disease-is-launched-114989074.html) 


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cardiff experts call for Alzheimer's action</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9ACB1168-1CCB-4BF2-83CE-6FE25B0C3AB6</gtr:id><gtr:impact>Cardiff experts have been at the forefront of calls to step up the battle against Alzheimer's Disease in the press and on national television following a leading international conference on the disease. Nationwide media coverage including the BBC news

Will lead to increased public awareness</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CNS Leadership Seminar: The quest to slow Alzheimer's disease progression</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5DC35F6E-2FC3-4D7A-9A37-032750168C22</gtr:id><gtr:impact>Provided a talk entitled &amp;quot;Genetic basis of Alzheimer disease susceptibility&amp;quot; at the CNS Leadership Seminar: The quest to slow Alzheimer's disease progression

Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://onenucleus.com/onenucleus-events?id=692</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>House of Commons presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F2350C56-DE86-4618-8533-47A29D69F899</gtr:id><gtr:impact>Alzheimer's Disease - causes, research

unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ART Public Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>7B19FA9B-772C-4D44-BE76-1254D61356A8</gtr:id><gtr:impact>Presented research findings as part of the ART public lecture &amp;quot;New Alzheimer's genes: What do they mean?&amp;quot;

Not Known</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC panorama</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0F0742DB-0612-4D67-BA6C-5D22877033C0</gtr:id><gtr:impact>BBC Panorama are following an EOAD participant. The initial interview was filmed by the BBC</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>IWA's Agenda magazine</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8C734DD4-F5BF-4C49-AF62-2C7EA26277E5</gtr:id><gtr:impact>Professor Julie Williams' Alzheimer's research is featured in the summer edition of IWA's Agenda magazine (Agenda, No 41 Agenda, Front Page and Pgs 48-49) 


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC Wales Dementia Week 2016</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>594831C3-64A0-45AB-B332-17364FD2990E</gtr:id><gtr:impact>Filming with BBC Wales's Owain Clarke on Thursday (12th May, 10-12). Interview is part of a package he's doing for Alzheimer's Awareness Week. Owain will be asking Prof Williams about Wales's research contribution; her own specific research and; look ahead at what's next.
Various excerpts were screened on BBC news throughout the week, featuring a number of different staff from the team at Cardiff. This raised awareness of our work and the profile of the team.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Young Onset Dementia: Different impact, positive solutions conference</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B9AD92DA-12C9-4948-97A6-C37AABDD5D6C</gtr:id><gtr:impact>This public meeting was held on 27th September, 2016. This was a recruitment opportunity.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://www.youngdementiauk.org/sites/default/files/Young%20Dementia%202016%20programme.pdf</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Probus Cardiff</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>94075F2A-A7B6-4172-B3AB-8F7EF2247534</gtr:id><gtr:impact>Provided a talk at the Combined Probus Club of Cardiff Inc.

Increased public awareness of Alzheimer's research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio Cymru Discussion on Alzheimer's disease. Participant = Alun Meggy, AD Team</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B1E0EE87-7DD4-4DA5-9463-C6778F044FB0</gtr:id><gtr:impact>Mr Alun Meggy took part in a Welsh discussion group broadcast live on Radio Cymru on 17th February 2017. Alun spoke in Welsh regarding Alzhiemer's disease research, and how we are working hard to develop our knowledge of this debilitating disease.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>alt.Cardiff blog entry</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>051362B1-836C-4F5A-AB98-4E0E2A0003FD</gtr:id><gtr:impact>Journalist Jessica Phillips interviews Julie Williams for an article on her blog</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>New breakthrough in Alzheimer's research</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A09EE06C-0AF9-450D-AC30-F0944DAF0143</gtr:id><gtr:impact>Professor Julie Williams, School of Medicine, comments on a new breakthrough in Alzheimer's research which has seen scientists unravel the precise function of genes known to make people more at risk of developing the illness. (Daily Express, 28.10.11, p.17) 


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Researchers Find Two More Genetic Risk Factors For Alzheimer's Disease</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>85989C2A-7742-4684-9E47-898DBF0D83C3</gtr:id><gtr:impact>Widespread worldwide broadcast, press and online coverage of a major new study into Alzheimer's led by researchers at Cardiff University. Including BBC, Channel 4, SKY and ABC news, The Telegraph, The Times, The Telegraph, The New York Times and all over major news channels / papers.

&amp;quot;The MRC Centre and research like this is changing our understanding of what causes the common form of Alzheimer's disease and provides valuable new leads in the race to find treatments and possibly cures.

&amp;quot;It also shows that other genes can be identified using this method, and we are already planning a larger study involving 60,000 people, which can be achieved within the next year.

&amp;quot;It is also important to recognise the contribution many Welsh people who have acted as subjects for this research over the years.&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The First Minister for Wales Carwyn Jones has appointed Cardiff University's Professor Julie Williams, School of Medicine, as Wales' Chief Scientific Adviser.</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>30A1A364-8FC4-48FD-9BDC-1CF906E7526E</gtr:id><gtr:impact>The First Minister for Wales Carwyn Jones has appointed Cardiff University's Professor Julie Williams, School of Medicine, as Wales' Chief Scientific Adviser.

Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Llandough Hospital</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>8F5783BB-C4B9-4C7F-91DF-733FF1C1D593</gtr:id><gtr:impact>Dissemination of recent findings

not known</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Genome wide association study of Alzheimer's disease</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>04EFC78E-E7A6-4B74-85BB-C0427AA5E24F</gtr:id><gtr:impact>Invited Plenary - International Conference on Alzheimer's disease (ICAD) - Vienna - July 2009


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British Science Festival 2016 Workshops</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6F682F32-C59F-42B4-A8A7-F40CEF90C03B</gtr:id><gtr:impact>We used VR tools to demonstrate the impact of dementia on people's everyday lives. These included using the experiences &amp;quot;A Walk Through Dementia&amp;quot;, our citizen science game &amp;quot;Sea Hero Quest&amp;quot;, some activities from out children's website, as well as hands on activities and memory games.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://www.britishsciencefestival.org/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Meeting</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>B9E5078E-B815-42DD-9B7E-10AFF8AACEAC</gtr:id><gtr:impact>We hosted a public meeting, supported by the Alzheimer's Research Trust, in September 2007. In addition to events hosted within the University we have also presented our research findings to carers, and individuals with AD at Alzheimer's Society regional meetings in Cardiff, Swansea, Blackwood and Caerleon and to the members of the Newport Carers Group and County Hosptial Carers Group, Pontypool.

These meetings contribute substantially to engaging the public in our research.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Alzheimers Society Visit</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>416F0CF7-E1A1-49F8-97CC-AA988E653712</gtr:id><gtr:impact>presented research findings to representatives of ART at a visit hosted by the Dean of Medicine, Cardiff University

not known</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Welsh presentation (Cardiff Science Society)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>22080D12-9BAA-4D74-8EB6-B97845D740BF</gtr:id><gtr:impact>A presentation was given in Welsh, by Alzheimer's Field Worker, Alun Meggy to the Cardiff Science Society on 21st November 2016. This was followed by questions and a discussion.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.cymdeithaswyddonolcaerdydd.org</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>New susceptibility genes for Alzheimer's disease</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2127A0D0-2333-4378-BC35-28AB121478C0</gtr:id><gtr:impact>Invited speaker - Eisai Symposium in Neuroscience (Dementia and Cognitive Dysfunction) - May 2010


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Eli Lilly Seminar</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EE05A8E4-7AC2-462D-92CB-217B568CBB83</gtr:id><gtr:impact>Defining the genetic architecture of Alzheimer's Disease

unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Global media coverage</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4F769B59-F43F-4A92-91BA-2F32EE96A637</gtr:id><gtr:impact>In September 2009 we published evidence of two new genes which are associated with susceptibility to Alzheimer's disease. This research generated substantial media interest both nationally and internationally. To see the BBC coverage of this story please visit: http://news.bbc.co.uk/1/hi/wales/8239773.stm. The story was covered in over 70 high quality publications (a full list is provided at the bottom this text). In addition, these findings have recently been recognised as one of the world's top 10 scientific breakthroughs of 2009 by Time magazine. See: http://www.time.com/time/specials/packages/article/0,28804,1945379_1944376_1944408,00.html Publications: Sky News Channel 4 News BBC Wales News ITV Wales Pittsburgh post - Gazette Daily Express Swansea Sound Washington Post New York Times Daily Telegraph Western Mail South Wales Echo The Independent The Irish Times Financial Times Sydney Morning Herald Ottawa Citizen Daily Mail Guardian The Mirror Nottingham Journal The Money Times The Sun Sindh Today Science Daily Belfast Telegraph Emax Health Malaysia News net Digital Journal Cambridge News Online Alzheimer's Society Real Radio Red Dragon Boston Globe Calgary Sun Norwich Evening News The Gov Monitor The Spokesman Review Food consumer Times of India Science News Medical News Today Top News NHS News Nature.com Blog Efitness.now Merinews Science Alert Pulse Today AHN Richmond Times - Dispatch The Birmingham News, Alabama Newsday, Melville NY The San Diego Union - Tribune, California El Nuevo Herald The Daily Gazette, New York St Paul's Pioneer Press Valley News Dispatch Chattanooga Times Free Press St Petersburg Times The Virginian - Pilot The Providence Journal The Gainsville Sun San Jose Mercury News The Journal Gazette Daily Times - Call The Tribune Visit Bulgaria Australian Ageing Agenda The News - Enterprise Ethiopian Review The Times - Tribune, PA South Florida Sun Sentinel ABC7 St Charles County Business Record The St Louis Countian

Such extensive media coverage has raised the profile of Alzheimer's disease and dementia research. Since the articles were published we have received numerous enquiries from members of the public wanting to contribute to our research. It has also promoted our own research nationally and internationally and we have developed collaborations as a direct result of this media coverage.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Calling for more funding for research into dementia</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>E35F68AF-31C9-409F-89B2-7C9B09A1AFF1</gtr:id><gtr:impact>Professor Julie Williams and Professor Mike Owen, Cardiff University are calling for more funding for research into dementia. (Western Mail, 9/2/11, p5)


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oxford Seminar Series</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>714BBABC-D6E7-483F-9696-8CC0D26C0411</gtr:id><gtr:impact>Invited speaker - Seminar Series,University of Oxford - June 2010


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Health and Care Research Wales Public Engagement talk 2016</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>43B224DC-7751-4F97-BBFD-394E522BD9F3</gtr:id><gtr:impact>Institute of Psychological Medicine and Clinical Neurosciences staff at Cardiff University School of Medicine were required to attend a one hour presentation on the importance of engaging with the public in scientific research. The aim was to give staff a greater appreciation of public involvement, and the benefits of this in research.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.healthandcareresearch.gov.wales/involving-the-public-in-your-research</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CADR Presentation to Minister</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>FB9BE203-66D3-4D36-91C1-4D81EE776E1A</gtr:id><gtr:impact>The Welsh Assembly Government Minister for Health visited Swansea University on 15th August, 2016. CADR staff/scientific leads were asked to prepare short presentations to inform the Minister of the on-going work of the research teams involved in CADR. Prof Julie Williams gave a brief presentation about the research of her team</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NGFN Symposium - Bonn</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A1B6F13E-35D9-4356-A9B7-B9487647DEE2</gtr:id><gtr:impact>Delivered talk entitled - Molecular Genetics in Alzheimer's Dementia

Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Marshall Scholars</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>7C908D1D-ECB9-4A23-A9FB-30613575FE52</gtr:id><gtr:impact>A talk entitled &amp;quot;New genetic findings in Alzheimers Disease&amp;quot; was presented to a group of Marshall Scholars

not known</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>US Fulbright Scholars Forum</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D2AD0502-3590-48B7-BBA7-95A851BC0B6D</gtr:id><gtr:impact>Spoke at the US Fulbright Scholars Forum .
Each year the Fulbright Awards team organise a week-long Forum for current US postgraduates and scholars to get together and explore a different part of the country. This January, over fifty grantees descended on the cities of Bristol and Cardiff to explore Wales and the West Country. Fulbright was generously hosted by the University of Bristol and the University of Cardiff who helped put on an excellent series of events.

Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>https://www.bfsa.org/wales</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Alzheimer's Research UK trustee talk and lab tour</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0CC8C532-0547-4F70-852F-047576F23600</gtr:id><gtr:impact>Presentation for lay members of Alzheimer's Research UK

unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Scientists at Cardiff University say they are a step closer to understanding the causes of dementia</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B5267D9D-1B40-46AD-A97A-0D59C7E6D24D</gtr:id><gtr:impact>Scientists at Cardiff University say they are a step closer to understanding the causes of dementia, thanks to a grant of nearly &amp;pound;250,000. The money will fund its brain bank, a centre which encourages people to donate their brains for medical research. Professor Julie Williams comments (BBC Wales On-line, 04.07.2013

Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.bbc.co.uk/news/uk-wales-22288025</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>New Alzheimer's genes revealed</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BC997CAB-ACDB-42F5-8AA1-3FFECF30AFCC</gtr:id><gtr:impact>Two potentially key genes linked to the development of Alzheimer's disease have been uncovered by UK researchers. Covered by major news channels including the BBC

Nationwide media coverage will lead to increased public knowledge</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ARUK Iceland donation press release</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5767B2E5-6788-46CB-8115-3E92167B3795</gtr:id><gtr:impact>A press release was issued announcing new funding from ARUK raised by Iceland foods

The press release mentioned research investigating Early Onset AD, this resulted in an increase in enquiries about research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.alzheimersresearchuk.org/news-detail/10984/Cardiff-researchers-lead-global-hunt-for-early-onset-Alzheimers-risk-genes/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Pratchett play for Alzheimer's</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>5D7BA71E-0684-4A5A-B279-F6F286272BA6</gtr:id><gtr:impact>A researcher at Cardiff University's National Centre for Mental Health has produced a play adapted from a Terry Pratchett novel in a bid to raise money for Alzheimer's Research UK.


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.cardiff.ac.uk/news/articles/pratchett-play-for-alzheimers-11246.html</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Will identifying susceptibility genes for Alzheimer's disease increase healthy ageing?</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B478FAB5-142F-40F4-AB73-4253FBBC2A53</gtr:id><gtr:impact>Invited speaker - United Nations Older Person's Day - Promoting active and healthy ageing - Cardiff, 30th September 2010 


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The Today Programme</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4D1367BB-B626-43F9-A406-EEA6865CFBBE</gtr:id><gtr:impact>JW on BBC Radio 4's Today programme talking
about her discovery of two new genes associated with Alzheimer's disease which could provide
valuable new leads in the race to find treatments and possibly cures for the devastating condition

Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>University's work on Alzheimer's</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>3E97AE4B-D577-479F-8335-BBD6691F1E8D</gtr:id><gtr:impact>Professor Julie Williams, School of Medicine, discusses the University's work on Alzheimer's. (BBC Radio Wales 17.2.11)


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Defining the genetic architecture of AD</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5316DBEE-93D7-4554-95D9-2BC36F2C55F6</gtr:id><gtr:impact>Rome 28th February 2011 - Invited speaker


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dementia research at the Cardiff City stadium</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>12A5EDC4-344C-4B91-B5C1-A0E269BC3033</gtr:id><gtr:impact>Professor Julie Williams, School of Medicine, will be among a set of leading speakers discussing dementia research at the Cardiff City stadium today (South Wales Echo, 22.05.11, Pg 10) 


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Building CanadaUK collaborations in neurodegenerative disease</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>98AE8589-CAEE-4F0F-AB4E-1B974F99779B</gtr:id><gtr:impact>Seminar at the High Comission of Canada

unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ARUK 2014 Annual Meeting</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4A24D0D3-2B26-46F9-A0A8-80C153B2BC53</gtr:id><gtr:impact>Julie Williams took part in a debate at the 2014 ARUK conference titled: Alzheimer's disease: The relative importance of Genes and Environment

The conference audience took part in the debate and positive feedback was recieved about this part of the conference.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:url>http://www.alzheimersresearchuk.org/conference-programme/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Distribution of news letter</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>E2BE2BB8-4939-4D97-9571-35B5A00395B6</gtr:id><gtr:impact>We distribute a 4-8 page newsletter annually to participants in our research, their families and healthcare professionals At present just over 1000 people receive our newsletter.

The newsletter helps engage the public in our research and we receive a large amount of positive feedback from it. We also hope that the newsletter has a positive impact on retention of participants in longitudinal aspects of our research.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dementia - A National Symposium 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0B8E7D89-C756-48D7-9E96-2259131F4773</gtr:id><gtr:impact>Delivered a talk entitled &amp;quot;Identifying and understanding genes which increase the risk of developing Alzheimer's disease and other dementias&amp;quot;

Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.open.ac.uk/science/main/files/science/file/Dementia%202013%20-%20Programme.pdf</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>WAG Seminar</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>6EB8CD39-6236-42BA-8F3D-1E5EB70DD720</gtr:id><gtr:impact>Presented recent research findings to policy makers

not known</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UN Older Persons Day - Cardiff</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>A1CAE636-609A-4F83-BDDD-84EFB9518B38</gtr:id><gtr:impact>Delivered talk entitled - Will identifying susceptibility genes for Alzheimer's Disease increase healthy aging?

Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ITV Wales interview Dec. 2015</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EE5279A6-FFBA-46DD-AC10-9956C944FFA0</gtr:id><gtr:impact>Interview with James Crichton-Smith at ITV Wales - ITV Wales are running a piece on early onset Alzheimers.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Genetic discoveries pinpoint new causes for Alzheimer's disease</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>4C2B0026-08FB-4346-B8DB-4AF80CFDC4D2</gtr:id><gtr:impact>Alzheimer's Society, Wales Regional Conference 14th July 2011 - Invited speaker


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>the country needs more scientists</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3EA28A8F-7D4E-41EA-AA3C-CDBD7BBB4817</gtr:id><gtr:impact>Wales' new chief scientific adviser, Prof Julie Williams, says the country needs more scientists. The Merthyr-born academic was appointed a CBE for her Alzheimer's research at the School of Medicine in Cardiff, and her appointment was announced last month (BBC Wales Today; BBC Wales On-line, 16.09.2013

Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.bbc.co.uk/news/uk-wales-24111210#?utm_source=twitterfeed&amp;utm_medium=twitter</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Kings College London Seminar</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>32D888F7-67EC-40CE-9007-659E73A2F2A6</gtr:id><gtr:impact>Delivered talk entitled - Psychiatric Genetics: Everything you always wanted to know but were afraid to ask

Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Westminster visit - Dementia</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8F7769CF-ECF5-423B-A6E2-4FB1C61E8F93</gtr:id><gtr:impact>Dissemination of research findings to parliamentarians

not known</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cardiff Scientific Society</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>BE7620CD-2755-4221-9C10-C2CA78DB6D42</gtr:id><gtr:impact>Talk entitled - The Genetics underlying late-onset Alzheimer's Disease

Not Known</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The International Genomics of Alzheimer's Project (IGAP)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>32732747-5175-40FE-B03F-1B2DDAD0C940</gtr:id><gtr:impact>A leading University expert in identifying genes that cause Alzheimer's disease will meet with some of the world's other figures for the first-time in Paris (Friday 19th November) in a bid help share knowledge and speed-up the genetic fight against the disease. The International Genomics of Alzheimer's Project (IGAP) is a major international consortium which brings together for the first time four of the world's leading research centres - including &amp;nbsp;Professor Julie Williams, School of Medicine, who leads the Genetic and Environmental Risk in Alzheimer's Disease (GERAD).


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Defining the genetic architecture of Alzheimer's disease</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>193ED54D-E3EA-4D63-B18E-67EF4A079CD9</gtr:id><gtr:impact>College of Mental Health Pharmacy , Leicestershire 30th September 2011 - Keynote speaker


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>404390</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ABBUK Brains for Dementia Research Programme (extension)</gtr:description><gtr:end>2018-03-02</gtr:end><gtr:fundingOrg>Alzheimer?s Brain Bank UK (ABBUK)</gtr:fundingOrg><gtr:fundingRef>504291</gtr:fundingRef><gtr:id>57211AB3-5025-4179-9743-66FB5206660C</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1882982</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>IDEA - Integrated DEmentiA research enviornment</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>1F1B272E-4DFF-4843-A1BA-6D6EE48C38C0</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>810998</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Defining genetic, polygenic and environmental risk for Alzheimer's disease using multiply powerful cohorts, focussed epigenetics and stem cells</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>9733590F-FE7B-4435-A75E-B4CD16C24511</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Welsh Government Scientific Centre for Aging and Dementia Research</gtr:description><gtr:end>2018-03-02</gtr:end><gtr:fundingOrg>Welsh Assembly</gtr:fundingOrg><gtr:fundingRef>507827</gtr:fundingRef><gtr:id>07350CFD-66B5-4470-950E-5B94F8D7ECA2</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>389000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PERADES: Defining genetic, polygenic and environmental risk of Alzheimer's disease using multiple power cohorts, focussed epigentics and stem cell metabolomics</gtr:description><gtr:end>2016-11-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:fundingRef>ARUK-PG2014-1</gtr:fundingRef><gtr:id>7D269F36-FDCE-4DBA-8EC0-DFF3BFFD46BA</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>136502</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Therapeutic targeting of impaired lysosomal flux in Alzheimer's disease (PhD Studentship, part-time)</gtr:description><gtr:end>2018-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>2F56EEF3-ECF0-41AC-9935-137AB68FC3E3</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>The work has also been published and has achieved a huge amount of media coverage. This discovery of three further genes associated with Alzheimer's disease could provide valuable new leads in the race to find treatments and possibly cures for the devastating condition. This patent application resulted from Julie Williams, Professor of Neuropsychological Genetics and Professor Mike Owen, Professor and Head of MRC Centre, completing the largest-ever joint Alzheimer's disease genome-wide association study (GWAS) involving 16,000 individuals. The patenting of theseSNPS is still in progress and a reveiew is currently underway to identify the best route to exploitation of the technology.</gtr:description><gtr:id>1F3352E6-CC64-4D88-836D-34FA91668AED</gtr:id><gtr:impact>This has had huge worldwide impact through media coverage and was originally highlighted in the press with the discovery of an additional 5 genes. We are currently in the process of seeking a licencee for the patented technology which encompasses a diagnostic test for the protected gene SNPs. Recent advances include generation of a polygenic score including the licensed SNPs for the detection of AD risk. We are working together with industry on basic genetic testing, cohort studies, cognitive test providers and pathway specific therapies for new ways in which to combat Alzheimer's disease.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:patentId>WO2011001135; NZ 596614; CAN 2,766,876; JP 2012-516841 and JP 2013-164509 ;AUS  201001208; US 13/376,485 and US 13/886,473; EP 10747062.7; CN 201080029259.9 and CN 201310280889.9; HK 12110195.8; UK 2766876</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Diagnosis of Alzheimer's Disease</gtr:title><gtr:yearProtectionGranted>2012</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Welsh Assembly Government Advisory Group on Dementia</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>7A18F9AD-1C85-4BD5-90DE-7ECCD1697A29</gtr:id><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Department of Health Advisory Group on Dementia</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0001BCDE-2552-4C7A-B26B-B2C3F6A3098C</gtr:id><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Chief Scientific Advisor to Alzheimer's Research UK</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C2BE858D-B745-4812-A8F9-29094E715669</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Deputy Director DPUK</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>158B6539-5B97-40BF-A97B-F4691C80ECBA</gtr:id><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Department of Health Advisory Group on Dementia</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C4714BBF-79B1-4FE7-8891-2F22D5B3D333</gtr:id><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Chief Scientific Advisor to Alzheimer's Research Trust</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>828D4656-27EE-4E5F-A8A7-4B42394EF0F3</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Department of Health Advisory Group on Dementia</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DB005A08-DF33-49A7-8992-70AE5FEA59E5</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Genome-wide association study data of over 3,000 AD cases and 7,000 controls</gtr:description><gtr:id>ED84FB45-53DD-48FE-AF02-0397BC5DE1BE</gtr:id><gtr:impact>multiple publications</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>GERAD GWAS</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Dataset from Illumina Exome chip platform (version 1.0 and v1.1), approximately 6,000 cases and 4,000 controls</gtr:description><gtr:id>8D722068-8793-476E-8961-6A8B6D1A0C54</gtr:id><gtr:impact>papers in press</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>GERAD Exome chip data</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>DPUK collection of information about the data held by each cohort</gtr:description><gtr:id>12D0B5E2-6521-4701-A00B-E1351F132048</gtr:id><gtr:impact>n/a</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>DPUK</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Mega-meta analysis data of over 17,000 AD cases and 30,000 controls</gtr:description><gtr:id>8983A672-7574-40B0-969C-F556B0F1158E</gtr:id><gtr:impact>Lambert et al. 2013 (PMID:24162737), Escott-Price et al. 2014(in press), Farrer et al. 2014 (submitted)</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>IGAP dataset</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have recently created a brain bank based upon the longitudinal sample, to provide the wider research community with multiple tissue samples on well characterised individuals.</gtr:description><gtr:id>CC751188-67C9-4398-9747-8DDAEA107CA9</gtr:id><gtr:impact>Multiple publications and media coverage</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Brain Bank - Alzheimers</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Cell lines created using genome editing tool</gtr:description><gtr:id>DCA8E836-0639-4993-B9D3-C346A42876B0</gtr:id><gtr:impact>none yet</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>CRISPR generated cell lines</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We are collecting a biological sample of early onset Alzheimer's disease individuals for research.
This includes phenotypic data and biological data and is set to become the largest EOAD biobank in the world.</gtr:description><gtr:id>E9CF335A-7A1B-4943-92D9-ACD7913B89C3</gtr:id><gtr:impact>This earlier more aggressive form of the disease will be studied in order to shed light on disease mechanisms and prospective therapies.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>EOAD cohort</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Cellular models in vitro</gtr:description><gtr:id>CF4DB7FB-F3DB-4380-A758-EF586D88180D</gtr:id><gtr:impact>unknown</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Human Stem Cell Modelling of Brain Disease</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Bacterial method to insert gene mutations of interest into cell lines</gtr:description><gtr:id>DC1FA8C8-E1C6-4053-9CF2-9DE5FEB3C52B</gtr:id><gtr:impact>none yet</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>BAC cell lines</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Brains; cases and controls</gtr:description><gtr:id>4601CCE4-A06B-4571-A7FF-E072D9E8EE27</gtr:id><gtr:impact>unknown</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Brains for Dementia Research</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>With 80,000 variants included to create a measure of risk of Alzheimer's disease, the polygenic score is an excellent predictive tool to determine case/control status with high accuracy. The polygenic score encompasses the majority of genetic risk of disease, and can be fine-tuned to identify the pathways involved in disease, for example, immune cell activity or endocytosis.</gtr:description><gtr:id>7A8823AC-8644-42AF-9B7B-048C5FC04043</gtr:id><gtr:impact>We are working to translate this method from the basic science environment in which it was created into a predictive tool used to select participants for clinical trials, based on their disease status and type. We are currently in discussions with a number of potential collaborators to take this forward.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Polygenic score</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>Bespoke analysis tool to perform the latest analyses on the largest UK datasets available.</gtr:description><gtr:id>9231DC12-640C-4950-9471-C7B14B2684DD</gtr:id><gtr:impact>Product still under development / improvement following user feedback.</gtr:impact><gtr:title>Dementia's Platform UK Biostatistics Tool</gtr:title><gtr:type>Software</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>Used to select cohorts of interest, and to put a research proposal to them for feedback under the DPUK research protocol.</gtr:description><gtr:id>AE4AF1CE-DB31-4C28-BBA0-75DA8D5FBF35</gtr:id><gtr:impact>Improvements ongoing to develop impacts.</gtr:impact><gtr:title>Dementia's Platform UK Cohort Selection Tool</gtr:title><gtr:type>Webtool/Application</gtr:type><gtr:url>http://www.dementiasplatform.uk/cohort-tools/</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9A84BBE0-D2E5-42CF-9CDC-ECE4AAB8B304"><gtr:id>9A84BBE0-D2E5-42CF-9CDC-ECE4AAB8B304</gtr:id><gtr:title>Linking protective GAB2 variants, increased cortical GAB2 expression and decreased Alzheimer's disease pathology.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f50f494061631e387b397ef9e7255462"><gtr:id>f50f494061631e387b397ef9e7255462</gtr:id><gtr:otherNames>Zou F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3B01DF1B-F3CA-4E04-9D3B-97FEEE11AADC"><gtr:id>3B01DF1B-F3CA-4E04-9D3B-97FEEE11AADC</gtr:id><gtr:title>Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/07e74972561be40ab721f911617b3191"><gtr:id>07e74972561be40ab721f911617b3191</gtr:id><gtr:otherNames>Lambert JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/092CC31E-B221-44FE-8C53-5EF87378D792"><gtr:id>092CC31E-B221-44FE-8C53-5EF87378D792</gtr:id><gtr:title>Predictors of developmental dyslexia in European orthographies with varying complexity.</gtr:title><gtr:parentPublicationTitle>Journal of child psychology and psychiatry, and allied disciplines</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f368750b6c5449f553dc21f810b8ee3b"><gtr:id>f368750b6c5449f553dc21f810b8ee3b</gtr:id><gtr:otherNames>Landerl K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9630</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/36D4D82D-954F-409C-A120-9D75343C7372"><gtr:id>36D4D82D-954F-409C-A120-9D75343C7372</gtr:id><gtr:title>Alleles that increase risk for type 2 diabetes mellitus are not associated with increased risk for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0c8d2dccb5c3338979e7f8a8641956f6"><gtr:id>0c8d2dccb5c3338979e7f8a8641956f6</gtr:id><gtr:otherNames>Proitsi P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/11498CBC-0F5C-4C8E-879B-F931D7AFB96E"><gtr:id>11498CBC-0F5C-4C8E-879B-F931D7AFB96E</gtr:id><gtr:title>A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4069f6f80abc3dca900b1ffc9ba77f6f"><gtr:id>4069f6f80abc3dca900b1ffc9ba77f6f</gtr:id><gtr:otherNames>Scott RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D050D745-6A75-4389-9C9C-80BCBF1FA81D"><gtr:id>D050D745-6A75-4389-9C9C-80BCBF1FA81D</gtr:id><gtr:title>Can Studies of Neuroinflammation in a TSPO Genetic Subgroup (HAB or MAB) Be Applied to the Entire AD Cohort?</gtr:title><gtr:parentPublicationTitle>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4752b222bbdee97e09071550d9255907"><gtr:id>4752b222bbdee97e09071550d9255907</gtr:id><gtr:otherNames>Fan Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0161-5505</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B5468787-E8DF-4AB8-94BE-A1501C188036"><gtr:id>B5468787-E8DF-4AB8-94BE-A1501C188036</gtr:id><gtr:title>Defining the Genetic Architecture of Alzheimer's Disease: Where Next.</gtr:title><gtr:parentPublicationTitle>Neuro-degenerative diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9da89c318f56fc7256d9d74b60d23229"><gtr:id>9da89c318f56fc7256d9d74b60d23229</gtr:id><gtr:otherNames>Sims R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1660-2854</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1DEC8E2A-95F4-45B8-9225-D4BD1AE18523"><gtr:id>1DEC8E2A-95F4-45B8-9225-D4BD1AE18523</gtr:id><gtr:title>Quantitative interaction proteomics of neurodegenerative disease proteins.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d0f118fe1d7289a14a5998bdd80aaca2"><gtr:id>d0f118fe1d7289a14a5998bdd80aaca2</gtr:id><gtr:otherNames>Hosp F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A1EA375E-7AF4-45C8-BCC1-AEF27274268D"><gtr:id>A1EA375E-7AF4-45C8-BCC1-AEF27274268D</gtr:id><gtr:title>A novel Alzheimer disease locus located near the gene encoding tau protein.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3e3a671aa40c3ab6ceb98c09b75b6095"><gtr:id>3e3a671aa40c3ab6ceb98c09b75b6095</gtr:id><gtr:otherNames>Jun G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/01751441-A4B9-44F7-A5EF-5E18310C96FB"><gtr:id>01751441-A4B9-44F7-A5EF-5E18310C96FB</gtr:id><gtr:title>Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/66a813233bf3cf77d42e145cf9dd01de"><gtr:id>66a813233bf3cf77d42e145cf9dd01de</gtr:id><gtr:otherNames>Salloway S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AA1C68EA-1971-4368-BFBF-240D5BA1AA69"><gtr:id>AA1C68EA-1971-4368-BFBF-240D5BA1AA69</gtr:id><gtr:title>No association of genetic variants in BDNF with major depression: a meta- and gene-based analysis.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c2bdd3a817ea3669bca79a9ef2335e60"><gtr:id>c2bdd3a817ea3669bca79a9ef2335e60</gtr:id><gtr:otherNames>Gyekis JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5C142C4F-7C2D-4C3F-BC18-18715680BF33"><gtr:id>5C142C4F-7C2D-4C3F-BC18-18715680BF33</gtr:id><gtr:title>Retinal ganglion cell dendritic degeneration in a mouse model of Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/27e875ffabc758478aeb78910874f5a6"><gtr:id>27e875ffabc758478aeb78910874f5a6</gtr:id><gtr:otherNames>Williams PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7EBA7FB9-30E2-4205-A150-9150DAC23228"><gtr:id>7EBA7FB9-30E2-4205-A150-9150DAC23228</gtr:id><gtr:title>Alzheimer's disease risk variant in CLU is associated with neural inefficiency in healthy individuals.</gtr:title><gtr:parentPublicationTitle>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d7ff36ac445a4f50de552bd38f4d5c80"><gtr:id>d7ff36ac445a4f50de552bd38f4d5c80</gtr:id><gtr:otherNames>Lancaster TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1552-5260</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/68E72BC6-1273-40B6-8174-F240CB797228"><gtr:id>68E72BC6-1273-40B6-8174-F240CB797228</gtr:id><gtr:title>Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dfb50ad82a115894d592e09569cffa3f"><gtr:id>dfb50ad82a115894d592e09569cffa3f</gtr:id><gtr:otherNames>Escott-Price V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B8A361E9-BCFA-43E9-B285-5CFCA656D033"><gtr:id>B8A361E9-BCFA-43E9-B285-5CFCA656D033</gtr:id><gtr:title>GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f5fd8a036b6ccf0bb9a8fec23f69321d"><gtr:id>f5fd8a036b6ccf0bb9a8fec23f69321d</gtr:id><gtr:otherNames>Cruchaga C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/16358DF5-4972-439D-968D-2483638712DC"><gtr:id>16358DF5-4972-439D-968D-2483638712DC</gtr:id><gtr:title>The Correlation between Inflammatory Biomarkers and Polygenic Risk Score in&amp;nbsp;Alzheimer's Disease.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5109e1a98eef0b7d0fee05867d6f9d86"><gtr:id>5109e1a98eef0b7d0fee05867d6f9d86</gtr:id><gtr:otherNames>Morgan AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B3804A72-B25D-4168-AD4B-FA64130EE5ED"><gtr:id>B3804A72-B25D-4168-AD4B-FA64130EE5ED</gtr:id><gtr:title>Genome-wide association study of CSF levels of 59 alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/409c0c9fd237532d04d3b40b2b89a73f"><gtr:id>409c0c9fd237532d04d3b40b2b89a73f</gtr:id><gtr:otherNames>Kauwe JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FB2086A0-CF81-4AB1-B99E-A9243E1E218D"><gtr:id>FB2086A0-CF81-4AB1-B99E-A9243E1E218D</gtr:id><gtr:title>Common polygenic variation enhances risk prediction for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dfb50ad82a115894d592e09569cffa3f"><gtr:id>dfb50ad82a115894d592e09569cffa3f</gtr:id><gtr:otherNames>Escott-Price V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EF31A152-7F8A-47CF-9BF0-3C0BD6FBB983"><gtr:id>EF31A152-7F8A-47CF-9BF0-3C0BD6FBB983</gtr:id><gtr:title>Decreasing the expression of PICALM reduces endocytosis and the activity of ?-secretase: implications for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>BMC neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fad3fe3498eb516a0c6977f23dc55b1f"><gtr:id>fad3fe3498eb516a0c6977f23dc55b1f</gtr:id><gtr:otherNames>Thomas RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-2202</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/23DEE74C-C327-427A-958F-45B0E7A2FD79"><gtr:id>23DEE74C-C327-427A-958F-45B0E7A2FD79</gtr:id><gtr:title>Evidence that PICALM affects age at onset of Alzheimer's dementia in Down syndrome.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/65378619cf887eea1aee93de2b16196b"><gtr:id>65378619cf887eea1aee93de2b16196b</gtr:id><gtr:otherNames>Jones EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/076DA839-3530-4F73-A2A9-0E1615343F76"><gtr:id>076DA839-3530-4F73-A2A9-0E1615343F76</gtr:id><gtr:title>Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cc6be3b3e5ee776d6c6cd87eccb0be6f"><gtr:id>cc6be3b3e5ee776d6c6cd87eccb0be6f</gtr:id><gtr:otherNames>Mok KY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/79324012-BE5D-4BA0-B0FF-20D12BC42E1E"><gtr:id>79324012-BE5D-4BA0-B0FF-20D12BC42E1E</gtr:id><gtr:title>Schizophrenia risk variants modulate white matter volume across the psychosis spectrum: evidence from two independent cohorts.</gtr:title><gtr:parentPublicationTitle>NeuroImage. Clinical</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3d5aac9693372f459cdfcd31d86b8b58"><gtr:id>3d5aac9693372f459cdfcd31d86b8b58</gtr:id><gtr:otherNames>Oertel-Kn?chel V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2213-1582</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8665683A-FDDE-4ED1-88B3-7EC10D7F0A06"><gtr:id>8665683A-FDDE-4ED1-88B3-7EC10D7F0A06</gtr:id><gtr:title>Shared genetic contribution to Ischaemic Stroke and Alzheimer's Disease.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4ff905ca396cdd019b10c080a5d07bcb"><gtr:id>4ff905ca396cdd019b10c080a5d07bcb</gtr:id><gtr:otherNames>Traylor M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E48E18FE-158E-4A6C-9B04-B335B11B9CE0"><gtr:id>E48E18FE-158E-4A6C-9B04-B335B11B9CE0</gtr:id><gtr:title>Estimation and partitioning of polygenic variation captured by common SNPs for Alzheimer's disease, multiple sclerosis and endometriosis.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e65ad8ad8d99155072e5805168e305c6"><gtr:id>e65ad8ad8d99155072e5805168e305c6</gtr:id><gtr:otherNames>Lee SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B89A802C-3517-45D7-B729-41A9893BBB1E"><gtr:id>B89A802C-3517-45D7-B729-41A9893BBB1E</gtr:id><gtr:title>Analysis of genome-wide association studies of Alzheimer disease and of Parkinson disease to determine if these 2 diseases share a common genetic risk.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d14c3a9646f0da9792d2b4276c13d04a"><gtr:id>d14c3a9646f0da9792d2b4276c13d04a</gtr:id><gtr:otherNames>Moskvina V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EC5F6CCF-E275-42DD-9EDF-EB07B574CFF2"><gtr:id>EC5F6CCF-E275-42DD-9EDF-EB07B574CFF2</gtr:id><gtr:title>A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/68ae0b5920edebc0579f77ebe7ddbb4e"><gtr:id>68ae0b5920edebc0579f77ebe7ddbb4e</gtr:id><gtr:otherNames>Fogh I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/043E57AF-A53B-41FA-9583-9C2CB283923F"><gtr:id>043E57AF-A53B-41FA-9583-9C2CB283923F</gtr:id><gtr:title>Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3aecd6c12e9d3fc88853b6503a8fc32d"><gtr:id>3aecd6c12e9d3fc88853b6503a8fc32d</gtr:id><gtr:otherNames>Desikan RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/877BFD02-72D1-43DD-BFE9-A889EA72A174"><gtr:id>877BFD02-72D1-43DD-BFE9-A889EA72A174</gtr:id><gtr:title>WHODAS 2.0 in prodromal Huntington disease: measures of functioning in neuropsychiatric disease.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0912cceea7e2c5cfb1bf99c74a99c813"><gtr:id>0912cceea7e2c5cfb1bf99c74a99c813</gtr:id><gtr:otherNames>Downing NR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8EEA0338-852D-4908-ABDA-C4C09C485D40"><gtr:id>8EEA0338-852D-4908-ABDA-C4C09C485D40</gtr:id><gtr:title>Missense variant in TREML2 protects against Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cc87a350717c41c65e8df353cdc7e915"><gtr:id>cc87a350717c41c65e8df353cdc7e915</gtr:id><gtr:otherNames>Benitez BA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7882B91E-C5DB-4083-8C2B-4F966D511D29"><gtr:id>7882B91E-C5DB-4083-8C2B-4F966D511D29</gtr:id><gtr:title>Genetic variation at the CELF1 (CUGBP, elav-like family member 1 gene) locus is genome-wide associated with Alzheimer's disease and obesity.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ddb5a877f0299e4888e47daa027ecb43"><gtr:id>ddb5a877f0299e4888e47daa027ecb43</gtr:id><gtr:otherNames>Hinney A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B6EB94E9-A863-459A-8067-2026CCB21949"><gtr:id>B6EB94E9-A863-459A-8067-2026CCB21949</gtr:id><gtr:title>Convergent genetic and expression data implicate immunity in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1229498ce393fd300290a6e5f48128bf"><gtr:id>1229498ce393fd300290a6e5f48128bf</gtr:id><gtr:otherNames>International Genomics of Alzheimer's Disease Consortium (IGAP)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1552-5260</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9C42D690-4C77-4810-838A-2255D805C094"><gtr:id>9C42D690-4C77-4810-838A-2255D805C094</gtr:id><gtr:title>Genetic overlap between Alzheimer's disease and Parkinson's disease at the MAPT locus.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3aecd6c12e9d3fc88853b6503a8fc32d"><gtr:id>3aecd6c12e9d3fc88853b6503a8fc32d</gtr:id><gtr:otherNames>Desikan RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8B0C5007-B28F-4F7D-A0DD-CEFFCC72C6F6"><gtr:id>8B0C5007-B28F-4F7D-A0DD-CEFFCC72C6F6</gtr:id><gtr:title>From molecule to clinic and community for neurodegeneration: research to bridge translational gaps.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/91e46d80372fd59501b4eb05128f2b88"><gtr:id>91e46d80372fd59501b4eb05128f2b88</gtr:id><gtr:otherNames>Brayne C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A1963E7B-7BAF-43D2-BB0D-ED2D857C5F04"><gtr:id>A1963E7B-7BAF-43D2-BB0D-ED2D857C5F04</gtr:id><gtr:title>Rare Functional Variant in TM2D3 is Associated with Late-Onset Alzheimer's Disease.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9a8fdf8a88169f15326d1dfa3e4a1230"><gtr:id>9a8fdf8a88169f15326d1dfa3e4a1230</gtr:id><gtr:otherNames>Jakobsdottir J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1DF308A6-F3D5-457E-AF20-8881A56725F0"><gtr:id>1DF308A6-F3D5-457E-AF20-8881A56725F0</gtr:id><gtr:title>Genetic predisposition to increased blood cholesterol and triglyceride lipid levels and risk of Alzheimer disease: a Mendelian randomization analysis.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0c8d2dccb5c3338979e7f8a8641956f6"><gtr:id>0c8d2dccb5c3338979e7f8a8641956f6</gtr:id><gtr:otherNames>Proitsi P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/552A4FD7-6ACD-4F54-A768-A2C46E06089B"><gtr:id>552A4FD7-6ACD-4F54-A768-A2C46E06089B</gtr:id><gtr:title>The TRiC/CCT chaperone is implicated in Alzheimer's disease based on patient GWAS and an RNAi screen in A?-expressing Caenorhabditis elegans.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/36688dfd02cdf9038c075b02a278b29d"><gtr:id>36688dfd02cdf9038c075b02a278b29d</gtr:id><gtr:otherNames>Khabirova E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E2673EE5-4EE3-4539-9F02-AB608EE9EF0B"><gtr:id>E2673EE5-4EE3-4539-9F02-AB608EE9EF0B</gtr:id><gtr:title>Evaluation of a Genetic Risk Score to Improve Risk Prediction for Alzheimer's Disease.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1e0c5456d49830593407efb7177c81be"><gtr:id>1e0c5456d49830593407efb7177c81be</gtr:id><gtr:otherNames>Chouraki V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1D876DD4-950F-423F-BA13-186B3FDC8242"><gtr:id>1D876DD4-950F-423F-BA13-186B3FDC8242</gtr:id><gtr:title>Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/69905c878941a37c1afe80c769859d11"><gtr:id>69905c878941a37c1afe80c769859d11</gtr:id><gtr:otherNames>Chapuis J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/33F24A04-78CE-4EE9-9520-A88EC9391358"><gtr:id>33F24A04-78CE-4EE9-9520-A88EC9391358</gtr:id><gtr:title>TREM2 variants in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/56b2d14505f1916bc463c5643c1c28d8"><gtr:id>56b2d14505f1916bc463c5643c1c28d8</gtr:id><gtr:otherNames>Guerreiro R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C14A481A-F29D-4CE7-A083-A8A80565BA9B"><gtr:id>C14A481A-F29D-4CE7-A083-A8A80565BA9B</gtr:id><gtr:title>Genome-wide association interaction analysis for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4c5650dbecb9504886b4a636f656329a"><gtr:id>4c5650dbecb9504886b4a636f656329a</gtr:id><gtr:otherNames>Gusareva ES</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D98D34DD-7765-4F9D-9AFD-AAE75496A8D1"><gtr:id>D98D34DD-7765-4F9D-9AFD-AAE75496A8D1</gtr:id><gtr:title>A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5a4db89997b8ce0c07217c5879f816fb"><gtr:id>5a4db89997b8ce0c07217c5879f816fb</gtr:id><gtr:otherNames>Deming Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CD874553-3125-4ECB-A398-49812208EE85"><gtr:id>CD874553-3125-4ECB-A398-49812208EE85</gtr:id><gtr:title>Polygenic score prediction captures nearly all common genetic risk for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dfb50ad82a115894d592e09569cffa3f"><gtr:id>dfb50ad82a115894d592e09569cffa3f</gtr:id><gtr:otherNames>Escott-Price V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DD30F443-7D89-43EA-AE0F-F1FBEA75E9F0"><gtr:id>DD30F443-7D89-43EA-AE0F-F1FBEA75E9F0</gtr:id><gtr:title>Genome-wide association interaction analysis for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4c5650dbecb9504886b4a636f656329a"><gtr:id>4c5650dbecb9504886b4a636f656329a</gtr:id><gtr:otherNames>Gusareva ES</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BCC3E822-EB30-42B6-B81A-28BF8AF677E3"><gtr:id>BCC3E822-EB30-42B6-B81A-28BF8AF677E3</gtr:id><gtr:title>Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/07e74972561be40ab721f911617b3191"><gtr:id>07e74972561be40ab721f911617b3191</gtr:id><gtr:otherNames>Lambert JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BCC95139-9F50-4000-A5CB-6D60C94DDFF8"><gtr:id>BCC95139-9F50-4000-A5CB-6D60C94DDFF8</gtr:id><gtr:title>Multimodal Brain Imaging Reveals Structural Differences in Alzheimer's Disease Polygenic Risk Carriers: A Study in Healthy Young Adults.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b83e49f203a8b6763dc9016d08071e47"><gtr:id>b83e49f203a8b6763dc9016d08071e47</gtr:id><gtr:otherNames>Foley SF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E03E0BE8-C776-49F2-BFA4-9295349D696F"><gtr:id>E03E0BE8-C776-49F2-BFA4-9295349D696F</gtr:id><gtr:title>A genome-wide study shows a limited contribution of rare copy number variants to Alzheimer's disease risk.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/028d3b2ceed7be9c07d74b670071bc7f"><gtr:id>028d3b2ceed7be9c07d74b670071bc7f</gtr:id><gtr:otherNames>Chapman J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A30E8BFB-2FE5-4CA9-AA70-717F020BC5CB"><gtr:id>A30E8BFB-2FE5-4CA9-AA70-717F020BC5CB</gtr:id><gtr:title>Analysis of genome-wide association studies of Alzheimer disease and of Parkinson disease to determine if these 2 diseases share a common genetic risk.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d14c3a9646f0da9792d2b4276c13d04a"><gtr:id>d14c3a9646f0da9792d2b4276c13d04a</gtr:id><gtr:otherNames>Moskvina V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EED8DD42-54A6-4DE8-8A31-DC1BE9465006"><gtr:id>EED8DD42-54A6-4DE8-8A31-DC1BE9465006</gtr:id><gtr:title>The TRiC/CCT chaperone is implicated in Alzheimer's disease based on patient GWAS and an RNAi screen in A?-expressing Caenorhabditis elegans.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/36688dfd02cdf9038c075b02a278b29d"><gtr:id>36688dfd02cdf9038c075b02a278b29d</gtr:id><gtr:otherNames>Khabirova E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/144633B9-6F54-4E70-A83D-91D1243BF8B2"><gtr:id>144633B9-6F54-4E70-A83D-91D1243BF8B2</gtr:id><gtr:title>GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f5fd8a036b6ccf0bb9a8fec23f69321d"><gtr:id>f5fd8a036b6ccf0bb9a8fec23f69321d</gtr:id><gtr:otherNames>Cruchaga C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/K013041/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>9A8BEDCC-D902-4C9A-8CCF-C974265EA3FB</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.4  Surveillance and distribution</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>